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ABSTRACT
Effects of Age and Early Life Ozone Exposure on the Developmental
Dynamics of Afferent Airway Neurons in Postnatal Rats
Leor C. Zellner
The environmental irritant ozone (O3) plays a role in airway inflammation and is known to
cause airway hyperresponisiveness especially in susceptible populations such as asthmatics
and young children. O3 exposure increases nerve growth fact (NGF) mRNA and protein levels in
the airways, and alters the expression of substance P (SP) in nodose and jugular afferent
airway neurons and in sensory nerve fibers in the airways. The growth and development of
vagal afferent neurons is in part regulated by NGF, and because these sensory neurons
continue to develop throughout postnatal life O3 exposures during this period may adversely
affect their development. The objectives of these studies were to 1) characterize the normal
postnatal development of vagal ganglia sensory neurons, tracheal epithelial innervation, and
NGF levels in lung lavage and 2) investigate changes in nodose and jugular ganglia neuron
number and SP content following acute O 3 exposure in early postnatal life.
Initial studies determined that NGF levels in bronchoalveolar lavage fluid (BALF) and
tracheal epithelial nerve fiber density (NFD) changed in an age-related manner, and both were
maximally increased on postnatal day (PD) 10. Preliminary studies conducted to determine an
efficient and accurate method for quantifying vagal sensory neurons used retrograde tracing
techniques to identify afferent airway neurons located in the nodose and jugular ganglia. A
novel quantification technique combining neuronal isolation, immunocytochemistry and flow
cytometry was developed. Age-related changes were also noted in afferent airway neurons,
which corresponded to the changes measured in NFD and NGF levels. These findings
indicated that the early postnatal development of airway sensory neurons and innervation
occurs in a rapid manner and may be influenced by NGF.
In the next set of studies, rats were exposed to O3 (2ppm for 3 hrs) on PD5 to evaluate
possible changes in neuronal development and SP content. A significant decrease in the total
number of nodose and jugular ganglia neurons was noted 16 days after the O3 exposure
(PD21), and the number of SP-containing airway neurons was markedly increased on PD28 (23
days after O3) compared with filtered air (FA) controls. No differences in the total number of
airway neurons between O3 and FA exposed groups were noted. These findings reveal that
early life O3 exposure can significantly alter vagal sensory neuron development.
In conclusion, sensory neuron development is significantly altered by exposure to O3 in
early postnatal life, and increases in the number of SP containing airway neurons so far
removed from the exposure, may provide insight into why early life O3 exposure enhances
airway responses to subsequent irritant exposures later in life.
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CHAPTER 1:
Introduction and Literature Survey
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Childhood asthma is a growing concern in major cities around the world. Understanding
how the airways change during development and how they are affected by exposures to
environmental air pollutants, such as ozone, is becoming of greater concern. This chapter
discusses afferent sensory innervation of the airways, the postnatal development of afferent
airway sensory neurons in the nodose and jugular ganglia, as well as how irritant exposures in
early life can alter airway growth and maturation. The information presented here will provide a
basis for comprehending the experiments discussed later on.

1.1 Structure of Lower Airway
1.1.1 General Structure and Function
The lower airway is comprised of two functional regions: the conducting region and the
respiratory region. The conduction region is made up of the trachea, main stem bronchi, lobar
bronchi, segmental bronchi, bronchioles, and terminal bronchioles. This region functions to
transport air to and from the respiratory region, as well as playing a role in the humidification
and temperature regulation of the inspired air (131). The conducting airways also filter and
remove particles from the air, and have antibacterial functions to aide in immunologic defense of
the body. The respiratory region contains respiratory bronchioles, alveolar ducts, alveolar sacs
and alveoli. This is the area of the airway where gas exchange occurs (131).
The conducting region can further be divided into extrapulmonary airway, outside of the
lung parenchyma, and intrapulmonary airway, within the lungs. The trachea and main bronchi
comprise the extrapulmonary airway, while the remaining bronchi and bronchioles, comprise the
intrapulmonary airway (131).
1.1.2 Airway wall structure
Below the basement membrane of the respiratory epithelium is the lamina propria, which
consists of connective tissues, blood and lymph vessels, resident immune cells including,
macrophages and mast cells, and autonomic and sensory nerve fibers, some of which may be
the intraepithelial fibers that have been detected in rats (3, 8). The trachea and main-stem
bronchi contain rings of C-shaped cartilage that act to prevent the airway from collapsing. The
cartilage is located on the anterior and lateral walls, and bands of smooth muscle run along the
posterior wall connecting the two ends of cartilage. Below the lamina propria is the submucosal
layer containing serous and mucous glands, additional sensory and autonomic nerve fibers, and
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blood vessels. Surrounding the extrapulmonary airway is the adventia, which acts as support for
the external wall of the airways, and contains blood vessels, nerves and lymphatic vessels.
As the airways transition from conducting to respiratory, the number of ciliated cells in
the respiratory epithelium gradually decreases as do the number of mucous glands and goblet
cells. Cartilage rings become plates and progressively decline, while smooth muscle becomes
helical shaped and gradually increases until the level of the respiratory bronchioles. At the level
of the terminal bronchioles, the epithelium is mostly comprised of cuboidal cells. In the
respiratory region, the epithelium is simple squamous epithelium, which helps to facilitate gas
exchange by decreasing the distance oxygen must diffuse to enter the pulmonary capillaries
(~0.5µm). The dense network of pulmonary capillaries encircling each of the ~300 million alveoli
creates a blood-air interface with a surface area of ~75m 2, further facilitating gas exchange by
increasing the diffusion rate for oxygen (131).
1.1.3 Cellular Components
Lining the airway is respiratory epithelium, which is characterized by a pseudostratified
columnar, ciliated epithelium with mucus-secreting goblet cells. The function of the respiratory
epithelium is to expel particulate matter that becomes trapped in mucus coating the epithelium,
which is moved upward by the beating of the cilia. The epithelial cells of the respiratory
epithelium fall into two classifications: ciliated and non-ciliated cells (135). Brush cells, serous
cells, mucous goblet cells, neuroendocrine cells (113), basal cells and Clara cells (found
primarily in the smaller bronchioles) fall into the latter class. The distribution of these cells is not
uniform through out the lower airways, and differs depending on the species (121).
Sensory innervation in the airways is a very important component in the maintenance of
pulmonary homeostasis. Under normal physiological conditions, sensory afferent activation
following noxious stimuli results in protective mechanisms designed to limit irritant infiltration in
the airways. Understanding afferent sensory innervation in the airways is important because
during chronic inflammatory and pathological states hypersensitivity of sensory afferents result
in exaggerated and injurious reflexes.

1.2 Development of Fetal Lung and Airway Innervation
Mammalian fetal lung maturation begins during embryogensis, which in humans starts
near the end of the 4th week of gestation. Lung growth then progress through three distinct
phases the pseudoglandular, canalicular and saccular stages with continued development
3

extending well into postnatal life (reviewed in 119). These stages of lung development have
been described in several different species including rats, primates, sheep and mice, though
timing of the phases will differ depending on species specific gestational periods (reviewed in
119). Figure 1-1 shows a comparison of human and rat fetal lung development. In both rats and
humans, postnatal life is a period of rapid and ongoing alveolarization, as the lung grows to
meet increasing metabolic demands. The accelerated rate of rat postnatal development makes
comparison with human postnatal development more challenging, however in general postnatal
day (PD) 2-6 are roughly equivalent to the period from infancy through preschool age in
humans. PD10-PD21 most closely correspond with school aged children through prepubescent
teenagers, with early adolescences and the onset of puberty in humans equating to PD28-42 in
rats (reviewed in 119).
Figure 1-1 (1)

Human

weeks 3.5-6

weeks 5-17

weeks 15-34

weeks 24-40

E9-E15

E16-E19

E19-20

E21

(280days/40 weeks)

Rat
(22 days/~3 weeks)

birth
species

(length of gestation )

embryonic

pseudoglandular

canalicular

saccular

Figure 1-1. Comparison of human and rat fetal lung development. Timeline of
prenatal lung development in humans and rats.
The following table (Table 1-1) highlights important developmental milestones in lung
development including the formation of airway innervation (summarized from 136).
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Table 1-1
Developmental
Phase
Embryonic

Pseudoglandular

Canalicular

Fetal Lung Development

Development of Airway innervation

* Formation of lung bud
- Rapid division as series of tubules branching in
dichotomous pattern
- Branching morphogenesis of epithelial tubules
(ET) forms proximal tracheobronchial tree
* Branching morphogenesis at peak levels
- Segmental bronchi present
- Critical developmental stage for formation of
conducting airways
* Lung lobular organization completed
* Airway smooth muscle (ASM) laid down at sites of
new growth of ET
- ET elongation = formation of continuous ASM
layer from trachea to growing tips
BY END OF PHASE:
* Branching virtually complete
* Dramatic changes in lung morphology
* Differentiation of pulmonary epithelium
- Formation of future air/blood barrier
* Surfactant synthesis
* Arterioles of bronchial circulation appear adjacent to
nerve trunks and bundles
* Capillary canalization of lungs begins
* Conducting and gas exchange regions are easily
distinguished
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* Neural crest cells (NCC) migrate from foregut to
lungs; differentiate
- Will become intrinsic pulmonary neurons
* ET surrounded by interconnect precursor ganglia
and loose nerve bundles
* Vagus nerve trunks visible
* Neural process connecting vagi to trachea and 1°
bronchi likely contain afferent sensory fibers from
vagal sensory ganglia
* Functional innervation of ASM
* Prolific amounts of vesicle traffic observed
BY END OF PHASE:
* Precursor neural tissues done proliferating
* Differentiating into mature neurons
* Spatial separation between ganglia due to
increased lung growth
* Ganglia become compact and spherical; migrate
away from nerve bundles
* Decrease in nerve bundle diameter
* Mucosal innervation is established followed by
mucosal vasculature
* Appearance of neurotransmitters
- SP+ fibers in ASM (humans)
- CGRP+ fibers in epithelium (rat & humans),
trachea, bronchial SM, and around blood vessels
(rat)

Developmental
Phase

Saccular

Postnatal

Fetal Lung Development

Development of Airway innervation

* Rapid lung growth
- Peripheral airways form widened airspaces
(saccules)
* Significant expansion of gas exchange region
* Bronchial mucosal circulation complexity increases
- Developing into microvessel network
* Arterioles follow nerve bundles
* Branching morphogenesis
* Enlargement of airways and gas exchange region
* Alveolarization
* Cellular differentiation
- Continues throughout lifespan of all species
- Tracheal epithelial differentiation is the most
extensively characterized

* Increased spatial separation between ganglia
* Maturation of ganglia and nerves
* Ganglia neurons and axons in nerve bundles are
ensheathed by glial cell processes
* Full expression of neurotransmitters
* SP+ C-fibers in epithelium (humans), lamina propria
(rats)
IN HUMANS
* Formation of basal nerve plexus
- Composed of sensory and motor neurons
- Lays just above basement membrane in
epithelium
* Nerves from plexus ascend between epithelial cells;
arborize; spread varicose fibers over apical surface
of epithelium
- Varicose fibers terminate in one or more swollen
varicosities containing SP & CRGP
- These varicose fibers are C-fibers
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1.3 Sensory Innervation of the Airway
1.3.1 Afferent Fiber Type
Numerous retrograde and anterograde tracing studies established that nearly the
entirety of sensory innervation in the lower airway originates in the nodose and jugular
ganglia located on the vagus nerves, with a smaller contribution coming from sensory
fibers originating in the dorsal root ganglia(7, 14, 38, 66, 80, 127, 137). The trachea and
main bronchi are innervated by fibers carried in the vagal branches of the superior
laryngeal and recurrent laryngeal nerves. Smaller branches of the vagus nerve innervate
the remaining portions of the airway (7, 14, 38, 66, 80, 127, 137). There are three types
of afferent sensory nerve fibers typically identified in the airway below the larynx: slowly
adapting stretch receptors (SAR), rapidly adapting stretch receptors (RAR) and
bronchopulmonary C-fibers (31, 60).
1.3.2 Slowly Adapting Stretch Receptors
SARs are an example of afferent nerves that respond to non-harmful distention
of the lung. This type of stretch-sensitive mechanosensor exhibits slow adaptation
responses to sustained lung distention. While highly sensitive to mechanical stimulation
SARs are relatively insensitive to chemical stimulation (60). Signal transduction in these
nerve fibers is conducted via myelinated A-! fibers that are between 1-5 µm in diameter
and have conduction velocities between 5-30 m/s (90, 101).
1.3.3 Rapidly Adapting Stretch Receptors
RARs are stretch-sensitive mechanosensors that rapidly adapt during maintained
inflation. They have the ability to readily respond to changes in the mechanical
properties of the airways and are functionally important in airway defensive mechanisms,
including initiation of the cough reflex (14). The greatest concentration of RARs in the
airways, established through electrophysiological studies, is around the carina, hilum,
and main bronchi, though they are found throughout the airways (60, 109). Upon
activation, signals from RARs are also conducted via A-! fibers, though generally they
have slower conduction rates than SARs (17, 31). The most striking difference between
RARs and SARs is that RARs are able to respond to a variety of stimuli including inhaled
irritants and endogenous mediators of inflammation (14, 60).
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1.3.4 Bronchopulmonary C-fibers
C-fibers are classified as such due to their slow conduction velocities (0.6-2 m/s;
45). The slow propagation of action potentials can be attributed to the fact that they are
thin (0.1-1 um), unmyelinated nerve fibers. C-fibers are highly chemosensitive, and in
nearly every mammalian respiratory system. They are vigorously activated by capsaicin,
the active ingredient in peppers of the Capsicum family (14, 84).
Histological and functional studies carried out in cats found that thin,
unmyelinated fibers account for the majority of afferent nerve fibers in the airways (4).
Bronchopulmonary C-fiber is the collective terminology for two classifications of C-fiber
afferents in the airways: bronchial C-fibers and pulmonary C-fibers. A distinction was
made between the two, based on their anatomic location within the airway; bronchial Cfibers are found within the airway mucosa, pulmonary C-fiber afferents innervate
intrapulmonary lung tissue. Bronchial C-fibers are most accessible to chemicals injected
into the bronchial circulation, while chemicals injected into the pulmonary circulation
were more readily accessed by pulmonary C-fibers (32, 83). This distinction however, is
not generally made in rats, since the circulatory accessibility is not as clear in smaller
animals (17, 61).
Though bronchial and pulmonary C-fibers have differing sensitivities and
responses to lung inflation, activation of bronchopulmonary C-fibers evokes a multitude
of defensive reflexes including rapid shallow breathing, apnea, bronchoconstriction,
mucus secretion and extravasation of plasma and cough (31, 32, 35, 148).
1.3.5 Connection to Central Nervous System
These three types of afferent nerve fibers travel within the vagus nerves and
synapse with second order neurons in the nucleus of the solitary tract (NTS). Though
the three fiber types generally terminate in the middle and caudal portions of the NTS
(73, 74), each fiber terminates in specific non-overlapping regions (34, 42, 79).
Appreciating the classifications of afferent sensory terminals in the airways and
the different fiber types involved in signal transduction is an important first step toward
understanding the consequences of hypersensitivity in these nerve terminals during
chronic inflammatory states. It is also pertinent to elucidate what is happening in the
soma of these afferents, upon activation.
8

1.4 Nodose & Jugular Ganglia Neurons
1.4.1 Anatomical Organization and Embryonic Origin
As previously mentioned, retrograde and anterograde tracing studies
demonstrated that the majority of airway afferent sensory innervation is from C-fibers
originating in the nodose and jugular ganglia (4, 7, 38, 66, 80, 127, 137). The nodose
(inferior) and jugular (superior) ganglia, located on the left and right vagus nerves at the
level of the jugular foramen (Figure 1-2), bilaterally innervate the lower airways, and also
provide sensory afferent innervation for other viscera including the heart and GI tract. In
rats and adult mice, the nodose and jugular ganglia are present as a single fused
ganglion containing the jugular ganglion in the rostral portion, and the nodose ganglion
in the caudal region (112).
Despite being in a single fused ganglion, nodose and jugular neurons exhibit
differences in afferent fiber type, sensitivity to pharmacological stimuli and airway
irritants, as well as variations in neuropeptide expression and reliance on differing
growth factors during development. These differences might be attributed to the differing
embryonic origin of the two ganglia. D’Amico-Martel and Noden (33) using the technique
of embryonic tissue transplantation, illustrated that jugular ganglion neurons originate
from the neural crest, while neurons in the nodose ganglion are derived from the third
and fourth epibranchial placodes.
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Figure 1-2 (2)

JF

ular

Jug

Nodose
Figure 1-2. Anatomical orientation of the nodose and jugular ganglia.
The nodose (inferior) and jugular (superior) ganglia are on the vagus nerve
(CNX) and are located just distal of the jugular foramen (JF) where the vagus
nerve exits the brainstem.
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1.4.2 Fiber Type and Sensitivity to Pharmacological Agents and Airway Irritants
Electrophysiological studies conducted in rats demonstrate that a large
percentage (75%) of afferent fibers originating in the nodose ganglion are C-fibers (90).
This work also determined that nodose ganglion neuron afferents have two additional
classifications of fiber type. Both are myelinated, fast conducting A-type fibers (>10m/s
conduction velocity); however, the fibers termed “Ah-type” had conduction velocities as
low as 4m/s and had broad action potentials (>2ms) that closely resemble those of
unmyelinated C-fibers. This study did not determine which tissue(s) these afferent fibers
were innervating; however, this does not rule out the possibility of airway innervation via
nodose C-fibers.
Another study using rats, attempting to discern if afferent fiber type of nodose
and jugular neurons could be determined on the basis of morphological markers as well
as response to pharmacological stimuli, utilized differences in the calcium transients of
cultured nodose and jugular neurons following capsaicin treatment as a way to
determine the associated fiber type (30). Capsaicin sensitivity, which was first
characterized in dorsal root ganglion, is considered the standard identifying trait of
nociceptive, C-fibers (150).
It was established that 58% of the viable neurons examined were capsaicinsensitive. Of neurons exhibiting increased calcium transients in response to a low dose
of capsaicin, 60% were nodose neurons, and 56% were jugular neurons (30). When a
maximal dose of capsaicin was administered, jugular ganglion neurons were significantly
more responsive than nodose ganglion neurons. From these results it was concluded
that jugular ganglion neurons have a significantly higher sensitivity to capsaicin (30),
which might indicate a higher concentration of C-fibers in jugular neurons. However, as
in the Li and Schild (90) study, the site of innervation was not established, in this
instance due to the use of cultured neurons.
As far as identifying afferent fiber type on the basis of morphology (soma size,
surface texture, color, or shape), no morphological differences were noted between
nodose and jugular neurons that responded to capsaicin treatment. However, it was
documented that capsaicin-sensitive neurons in both ganglia were predominantly less
than 35 µm in diameter, and that as soma size increased, the percentage of neurons
responsive to capsaicin decreased (30).
11

A much clearer picture of the origin of sensory afferent nerve fibers in the airways
exists in the guinea pig. Studies have ascertained that the afferent fibers of nodose
ganglion neurons are myelinated, fast conducting A-! fibers, whereas the afferent fibers
of jugular ganglion neurons are an equal mixture of myelinated A-! fibers and
unmyelinated C-fibers (127). Though some differences have been noted, these findings
have, for the most part, been generally accepted as the organization of vagal sensory
afferents in other mammalian species.
An additional study employing electrophysiology examined the sensitivity of rat
airway vagal afferents to pharmacological (capsaicin), irritant (cigarette smoke), and lung
inflation stimuli in relation to conduction velocities (60). This investigation concluded that
in rat airways, a small percentage of A-! fibers are mildly stimulated by chemical
irritants, but C-fibers are the primary chemosensitive afferents; however, location of the
soma associated with the nerve fibers was not determined (60). Studies in guinea pigs
have determined that nodose ganglion A-! afferents are stimulated during allergic airway
inflammatory events, resulting in increased tachykinin gene expression (49). Taken
together with the findings of the Ricco et al. (127) study, the conclusions of the Ho et al.
(60) study indicate that the A-! fibers stimulated following irritant exposure could be
afferents originating in nodose neurons.
1.4.3 Neuropeptide Expression
Neuropeptides constitute one of the largest families of extracellular messengers,
and can act as neurotransmitters, hormones, and paracrine factors. In the airways the
release of neuropeptides such as the tachykinin, substance P (SP), results in
vasodilation, increased vascular permeability, and edema.
In primary cultures of rat postnatal nodose and jugular ganglia neurons, SP
immunoreactive cell bodies were detected in soma from both ganglia (99). However, in
cultures containing both nodose and jugular neurons the levels of SP produced and the
numbers of immunoreactive cell bodies were 2-3 times higher when compared with
primary cultures containing exclusively nodose ganglion neurons. Interestingly, the
amount of SP measured in nodose only primary cultures increased the longer the
neurons remained in culture (97).
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SP immunoreactivity in nodose and jugular ganglia neurons of rats, mice and
guinea pigs colocalizes with the neuropeptides neurokinin A (NKA) and calcitonin-gene
related peptide (CGRP; 39, 58, 104). NKA is a potent bronchoconstrictor, while CGRP
acts as a vasodilator. Though neurons in both ganglia express the same neuropeptides,
the amounts of each varied between nodose and jugular neurons, which might account
for the differing responses of nodose and jugular neurons following afferent nerve
activation.
1.4.4 Growth Factor Reliance
Numerous studies in several different species have established that neurons in
the nodose and jugular ganglion require different growth factors for their survival.
MacLean et al. (98) found that adding the neurotrophin, nerve growth factor (NGF) to
primary cultures of early postnatal nodose neurons had no effect on neuronal survival.
Work employing the use of transgenic mice has helped to elucidate trophic needs
of vagal sensory neurons. Experiments using NGF -/- mice determined that there was
no change in neuron number in nodose ganglia; however, there was a significant
depletion in the number of jugular neurons, when compared to wild type controls
(reviewed in 134). However, Forgie et al. (50), using a different NGF -/- transgenic
model, found that there were a small population of nodose neurons that were supported
by NGF.
When brain derived neurotrophic factor (BDNF) knock out mice were examined,
significant losses in nodose neurons were detected, while the number of jugular ganglia
neurons remained unchanged (reviewed in 134). A group using transgenic mice that
over-express BDNF found that the number of neurons in the nodose ganglion was
selectively increased, while the number of neurons in other ganglia did not change in
number (86).
Nodose and jugular ganglia neurons have differing trophic support requirements,
as well as differences in embryonic origin, neuropeptide expression and sensitivity to
inhaled irritants. These dissimilarities may all be important factors in determining the
severity of the response that is generated upon activation of airway afferent nerves.
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1.5 Afferent Nerve Action
The afferent sensory nerve fibers in the airways, can be activated by a multitude
of noxious stimuli including: capsaicin, cigarette smoke, ozone, allergens, bradykinin,
low pH, ether, formalin, SO2, (TDI), histamine, methylcholine, prostaglandins,
leukotrienes, cold air, and hypertonic saline (reviewed in 94, 100). The action potentials
generated as a result of depolarizing events at sensory nerve endings are propagated
toward the central nervous system, as well as through the antidromic conduction of
impulses through terminal arborizations of sensory afferent nerve fibers. The peripheral
signals being conducted at the collateral branches to unstimulated nerve endings have
been termed an axon reflex (10).
Information arriving at the NTS in the brainstem, from nodose and jugular
afferents in the airways, elicits differing responses depending on which receptor type
(SAR, RAR, C-fiber) was activated in the airways(78). Signals conducted via SARs
affect the Breuer-Hering reflex. RAR stimulation initiates gasping and cough reflexes. Cfiber afferent transmission results in rapid, shallow breathing and apnea (78).
Within the airways, antidromic stimulation of nociceptive afferent fibers initiates
neuropeptide release from sensory nerve endings, leading to neurogenic inflammation in
the airways (10). A number of physiological and pathological functions in the airways are
mediated by nodose and jugular sensory afferents and the neuropeptides released from
these nerve fibers.

1.6 Neuropeptides in the Airway
SP was first described in 1931 by von Euler & Gaddum in the brain and intestine
as a smooth muscle-contracting substance, and a vasodepressor (147). SP is an 11amino acid peptide (29) localized in nodose and jugular neurons as well as in peripheral
nerve fibers within and beneath the respiratory epithelium, amongst bundles of smooth
muscle, encircling blood vessels and submucosal glands, and in close relationship to
resident immune cells (72). The synthesis of SP in nodose and jugular ganglia neurons
is the result of preprotachykinin-1 gene expression. This gene contains four different
transcripts capable of producing SP, thereby increasing the probability that SP will be
generated upon gene expression (124). Helke et al. (58) found that post-translation
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modifications of SP occur during peptide storage in vesicles and axonal transport to
nerve terminals.
SP exerts its effects in the airway through preferentially binding with neurokinin 1
(NK-1) receptors, though it may also act through the NK-2 and NK-3 receptors (116). In
the lower airways receptors have been localized on the epithelium, small blood vessels
and glands in the lamina propria (19, 111, 118, 129). Binding of SP with NK-1 initiates
receptor-mediated inflammatory responses characterized by plasma extravasation,
vasodilation and mucus secretion (8, 68, 96). The actions of SP in the airways are
terminated through rapid degradation by the tissue peptidase neutral endopeptidase and
angiotensin-converting enzymes, which have been localized to tissues that also have
NK-1 receptors (19, 75, 111, 118, 129). Cigarette smoke-induced neurogenic
inflammation in rat has been show to be partially mediated by SP NK-1 interaction,
characterized by plasma extravasation and goblet cell exocytosis (108). NK-1 receptors
are localized to endothelial cells in postcapillary venules and SP binding with NK-1
results in endocytosis of the ligand receptor complex. Vagal stimulation increased the
number of NK-1 immunoreactive endothelial cell endosomes, indicating that SP may
have a direct effect on endothelial cells (20). This direct effect of SP on plasma
extravasation in endothelial cells of the postcapillary venules in rat trachea was later
demonstrated through i.v. injections of SP. Within 20 sec of injection intracellular gaps
appeared between endothelial cells, peaking in numbers after 1 min, and then
decreasing with a half life of 3.2 min (106). The gaps between endothelial cells
accounted for ~ 3% of the surface area of postcapillary venules.
SP release from sensory afferents in the airways has also been shown to
modulate immune cell functions, including T-lymphocytes proliferation, macrophage
activation, enhanced macrophage and neutrophil phagocytosis, lymphocyte, neutrophil,
eosinophil, and monocyte chemotaxis, enhanced cytokine release from activated
monocytes and endothelial cell proliferation (9, 28, 55, 72, 81, 102, 115, 139).
Under normal physiological conditions the actions of SP described here are
important in protecting the airways when noxious stimuli are encountered. It is when
pathological states induced by chronic inflammatory events, that the effects of SP have
detrimental consequences.
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1.7 Neurotrophins
The neurotrophins (NTs) are a group of structurally related proteins whose
primary function is regulating the survival and differentiation of neurons in both the
peripheral and central nervous system (24). The group includes NGF, BDNF,
neurotrophin-3 (NT-3), and neurotrophin 4/5 (NT-4/5). NTs act primarily as targetderived paracrine and autocrine trophic factors (125), and are released from nerveassociated cells such as glial cells, Schwann cells and fibroblasts (88, 89).
As previously discussed, the NTs, NGF and BDNF, are responsible for the
survival of nodose and jugular ganglia neurons, and have been shown to differentially
affect the capsaicin-sensitivity of airway C-fibers in vitro (151). To exert their effects on
particular neuronal subsets, NGF and BDNF act through specific high affinity (KD10-11)
tropomyosin-related kinase (Trk) receptor tyrosine kinases. NGF preferentially binds to
TrkA, BDNF and NT-4/5 to TrkB, and NT-3 to TrkC (114). NTs can also bind the low
affinity (KD10-9) pan-neurotrophin receptor p75NT(82).
Studies have determined that NTs also act as mediators of inflammation, by
altering the expression of neuropeptides that are released from sensory nerve terminals
and through direct interactions with immune cells in both human and animal models (18,
21). Tachykinin production in nodose and jugular ganglia neurons is increased when
levels of NGF and BDNF are increased (65, 91, 97, 138). The respiratory epithelium
and immune cells, including mast cells, T and B-lymphocytes, and activated
macrophages that are present in or recruited to the airways during inflammatory events,
produce and release NTs (21, 22, 43, 76, 87, 141, 144). The interaction of NTs,
neuropeptides, and immune cells in the airways leads to inflammation that is
characteristically seen in asthma.

1.8 Neurogenic Inflammation
Neurogenic inflammation is the term coined by Jancso et al (69), to describe the
increase in vascular permeability, plasma extravasation, and tissue swelling occurring in
the skin and eyes when sensory nerves were stimulated by topical administration of
irritants or by antidromic electrical stimulation (68, 69). Lundberg et al (95) were the first
group to describe neurogenic inflammation in the airway. They found that inhalation of
cigarette smoke, administration of capsaicin or electrical stimulation of the vagus nerve,
16

induced an increase in plasma protein extravasation in the airways. The effects were
abolished following pretreatment with capsaicin or a SP antagonist, and it was noted that
exogenous SP given following depletion of SP from sensory nerve fibers elicited the
same effects as the noxious stimuli. These results led them to hypothesize that SP
released from capsaicin-sensitive nerve fibers mediates neurogenic inflammation in the
airways (93, 96).
When a noxious stimulus such as ozone, cigarette smoke, or house dust mite
allergen is introduced into the airways of a sensitized subject many processes are
initiated. Cells in the respiratory epithelium increase mucus secretion and in some
cases epithelial cell sloughing is noted. The epithelium releases BDNF, NGF, other
growth factors, and inflammatory cytokines, which activate and recruit immune cells to
the airway. As well, airway wall thickness increases through smooth muscle hyperplasia
and a thickening of the lamina reticularis. Activated T-cells release mediators
(cytokines, NTs) that cause goblet cell metaplasia, along with activating B-cells and mast
cells. Mast cell degranulation results in the release of histamine, which acts on the
epithelial cells and goblet cells, as well as activating sensory nerve terminals initiating an
axon reflex. The antidromic and central signaling in nodose and jugular sensory
afferents leads to bronchoconstriction, vasodilation and increased vascular permeability
through the actions of neuropeptides released at terminal arborizations (Figure 1-3).
The increase in SP levels in the airways also stimulates mast cell activation. The release
of NTs from immune cells and the epithelium causes an increase in nodose and jugular
neuron SP production and release (51).
Several different studies have shown that neurotrophins can mediate neuronal
plasticity in inflammatory conditions, such as asthma (40, 41, 91), which has only fueled
the search for ways to translate these basic science discoveries into clinically relevant
treatments.
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Figure 1-3 (3)
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1.9 Neurotrophins and Respiratory Disorders
Although neurotrophins were initially thought to be involved exclusively in the
survival and maintenance of neuronal populations, as is evident from the explanation of
neurogenic inflammation above, neurotrophins have a more diverse role, particularly in
pathological conditions such as asthma. Asthma is characterized by airway
inflammation, bronchoconstriction, and airway obstruction and is associated with altered
neuronal control of the airways (24, 44, 48).
In searching for the role that neurotrophins have in asthma pathogenesis, several
interesting discoveries have been made by examining human asthmatics. Increased
levels of neurotrophins were noted in the bronchoalveolar lavage fluid (BALF) of allergic
asthma patients following allergen challenge (146). Another study found that NGF is
increased in the serum of asthma patients (18); this increase was continuous and
independent of a recent asthma attack.
The role of neurotrophins in other airway inflammatory disorders has been
examined using animal models. Respiratory syncytial virus (RSV) infects nearly all
children before they are two years old (54), and it is thought to be a risk factor for
developing asthma later in life (117). It has been demonstrated that NGF is increased in
the lungs following RSV infection (63). This same group showed that after pretreatment
with anti-NGF antibodies, the neurogenic inflammation seen following RSV infection was
abolished. In addition, NGF is released in the airways following irritant exposures (27,
64, 130, 145, 149, 152), and neurotrophins can enhance airway responses to
inflammatory stimuli (15, 16, 122, 123). In an allergic airway inflammation model it was
shown that treatment with BDNF or anti-BDNF antibodies did not affect inflammation
(23). However, it was demonstrated that treatment with exogenous BDNF increased
airway responsiveness, and that treatment with anti-BNDF antibodies attenuated the
hyperresponsiveness seen in ovalbumin-sensitized mice (23). This indicates that NGF
and BDNF may be working in concert to produce the symptoms seen in asthma patients.
As neurotrophins have a role in inducing tachykinin gene expression (91), and act as
mediators of inflammation, attempting to elucidate the exact role that NGF has in asthma
and other inflammatory respiratory disorders is of great importance.
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1.10 Ozone and Early Life Exposures
1.10.1 Ozone (O3)
Ground level O3 is a pollutant and a main component in urban photochemical
smog. It poses a “significant health risk” to susceptible populations, particularly
asthmatic children(1). Ground level O3 is the product of a sunlight-catalyzed chemical
reaction between volatile organic compounds (VOC) and nitrogen oxides (NOx) present
in the air (25). Sources of VOC and NOx include gasoline vapors, and automobile
exhaust as well as industrial manufacturing and electric utilities emissions (25). O3 can
act to remove hydrocarbons like those found in gasoline vapors, from the atmosphere;
however, the products of that reaction are also key components of photochemical smog
(25). This type of air pollution is present in nearly every city, though it more prevalent
urban areas located in warm, sunny, dry climates where warm upper air can prevent
vertical circulation (6). Metropolitan areas such as Houston and Los Angeles with a
substantial number of vehicles on the road each day are examples of O 3-prone areas in
the United States (1, 2).
O3 acts as an oxidizing agent and inhalation of O3 can cause clinical symptoms
ranging from mild headaches and burning eyes, to shortness of breath, chest pain,
wheezing, and coughing (107). O3 exposure can also exacerbate emphysema and
asthma symptoms, augment lung inflammation and cause attenuated lung function (13,
57). These effects can be both transient and prolonged. Increased numbers of
emergency room admissions for respiratory illnesses, like asthma, have been correlated
with high concentration of ground level O 3 (26, 128, 142, 154). A recent article by Jerret
et al., described a significant increase in the rates of respiratory related deaths following
long-term exposure to increasing concentration of O3 (70). This study also revealed that
the risk of death from a respiratory related illness or disease is 30% more likely for
people living in metropolitan areas prone to the highest levels of O 3 when compared to
areas with the lowest measured O3 concentrations (70).
To demonstrate the physiological effects of O3 exposure studies in human
subjects (62) and numerous animals models including rats (46), mice (110), dogs (105),
and guinea pigs (53) and have been conducted. O3 exposure causes pathological
changes including damage to airway epithelium, airway hyperresponsiveness (AHR) and
pulmonary inflammation (12, 56, 85, 140, 153). Neutrophil influx in the trachea and
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bronchoalveolar space and increased serum protein levels in lavage fluid are
characteristic inflammatory responses observed following exposure to O 3 (5, 11, 36, 37,
77, 120). A characteristic feature of AHR, increased airway smooth muscle (ASM)
response to broncho-constricting agonists, is also noted (59). Though the downstream
effects of O3 exposure such as the induction and release of neurotrophins and
tachykinins are well documented, the exact mechanisms responsible remain unclear.
1.10.2 Early Life Exposures
Emerging evidence in both human and animals models of asthma and other
respiratory disorders shows that early life exposures can alter airway responses to
noxious-stimuli later in life. Early life ozone exposures in mice have been shown to have
detrimental effects on airway functions and are known to cause AHR (46, 132, 155), a
defining feature of asthma. Studies examining the effects of early life ozone exposure on
postnatal rats have revealed that multi-day O3 exposures between PD1 and PD15 result
in an increased percentage of SP immunoreactive nerve fibers in ASM 24 hrs after O3
when compared with controls (67). No differences were found in animals that were
exposed to ozone later in postnatal life. As part of the same investigation Hunter et al.,
demonstrated that combining early life (PD4) O 3 exposures with a subsequent exposure
later in postnatal life (PD28) resulted in significant increases in SP innervation in ASM,
as well as increased lung resistance and decreased dynamic compliance when
compared to values measured from rat pups initially exposed to O3 on PD21 (67). Rats
exposed to ozone between postnatal days (PDs) 2 and 6 and then exposed to either
filtered air or ozone on PD 28, had increased percentages of SP immunoreactive nerve
fibers in airway smooth muscle when compared to unexposed animals or rat pups
exposed later in life (67).
In studies examining the effects of early life exposure to sidestream cigarette
smoke, mice were exposed to filtered air or cigarette smoke for 10 consecutive days,
beginning at three different time points, i.e., gestational day (GD) 7, PD2 or PD21, and
then exposed to cigarette smoke on PD59 (152). Groups initially exposed to cigarette
smoke on either GD7 or PD2 had significantly altered lung function, increased
percentage of SP immunoreactive nerve fibers in the airways, and increased levels of
NGF in lavage fluid measured 24 hrs after reexposure to sidestream smoke on PD 59,
when compared to mice initially given cigarette smoke on PD21 or those exposed to only
FA at GD7 or PD2 (152). Research done in neonatal rats has found that side-stream
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tobacco smoke exposure during the gestational and postnatal periods produced
reductions in lung functions at eight weeks of age even when smoke exposure was
terminated at PD 21 (71).
These studies point towards the possibility of the existence of a critical period
during the postnatal development of the airways, when noxious stimuli can more
significantly affect normal defensive airway functions regulated by sensory nerve
afferents, causing them to become increasingly sensitive to later insults. To examine the
possible role of NGF in this proposed critical period, Hunter et al. (64) first measured the
concentration of NGF in the bronchoalveolar lavage fluid, and relative levels of NGF
mRNA in tracheal epithelial cells, from animals exposed to ozone at PD 6 and then
reexposed on PD 28. On PD 29, both NGF protein in lavage fluid and relative NGF
mRNA levels were significantly increased over all other groups, including animals that
were initially exposed to ozone on PD 21. In a second set of experiments, animals were
administered NGF intratracheally at PD 6 and then exposed to ozone on PD 28.
Increases in SP immunoreactivity in both the nerve fibers innervating the extrapulmonary
smooth muscle, and cell bodies of airway specific neurons in vagal ganglia were noted
(64). This study demonstrates that NGF released in the airways during early life may
play a key role in the development of the afferent nerve hypersensitivity that is seen
following ozone exposure later in life.
Studies examining the effects of early life exposures in humans have found that
early respiratory infections correlate with persistent wheezing and asthma in children
(103) and severe viral infections in infancy are associated with asthma in teens (133). It
has also been shown that in children, ozone can cause increases in asthmatic
symptoms even at concentrations below the U.S. Environmental Protection Agency
standard (52), and hospital admissions for asthma increase on days of high ambient
ozone concentrations (47, 143). Studies have found that high ozone levels in Mexico
City have been positively correlated with infant mortality (92). Inhalation of
environmentally relevant levels of ozone causes increased specific airway resistance
and breathing frequency and a decrease in tidal volume, forced vital capacity and total
lung capacity (13, 57). One study was conducted to examine if air pollution can influence
the airway inflammation and decreased lung function seen in children with mild asthma,
who live in urban centers (126). The children were moved from the urban area to a rural
area in an attempt to discern if decreased air pollution would result in an attenuation of
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their asthma symptoms. Lung function, along with inflammatory biomarkers, such as
numbers of nasal eosinophils were measured before and seven days after the move to
the rural area. Rapid decreases in airway inflammation and marked improvement in
lung function were noted within the seven-day period of being in an area of better air
quality (126).

1.11 Conclusions
Taken together, these studies demonstrate not only the immense influence that
early life exposures have on developing airways, but the need for a clearer
understanding of the underlying mechanisms at work in the process of airway neural
remodeling.
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2.1 Objective 1: Characterize the normal postnatal development
of nodose and jugular ganglia sensory neurons, tracheal
epithelial nerve fibers, and the concentration of NGF present in
the airway lumen.
Previous studies examining the postnatal development of sensory neurons from
rat nodose ganglia are contradictory in that one study indicated nodose neuron number
decreased from birth until approximately PD15, while a separate group reported no
change in nodose neuron number from birth through adulthood. However, neither of
these studies evaluated specific subsets of neurons, such as those projecting to the
airway, nor did they consider neurons in the jugular ganglia. Experiments examining
changes in tracheal epithelial innervation have been conducted; however in many
instances results are reported as changes in a specific peptide (e.g. SP). Studies
utilizing protein gene product-9.5 (PGP-9.5) immunohistochemistry to identify all
innervating nerve fibers have been completed but most determined changes in total
nerve fiber density (NFD) following manipulation of normal development. Overexpression of NGF in the airways affects airway innervation and its actions as a trophic
factor for sensory neurons innervating the airways has also been thoroughly
documented. However, the levels of NGF present in the airways during normal postnatal
development have not been extensively studied.
Chapter 3 presents studies that examined the normal postnatal development of
tracheal epithelial innervation between PD6 and PD28, as well as quantifying the
concentration of NGF measured in BALF during the same time period. Studies
presented in Chapter 4 detail the preliminary experiments conducted to determine the
optimal method for quantifying neurons. In Chapter 5, the quantification of both total
nodose and jugular sensory neurons and neurons innervating the airway (airway
neurons) during postnatal life is presented.
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In Objective 1, I postulate that the sensory neural development of the airways
(airway neuron number and tracheal epithelial NFD) will correlate with the levels of NGF
present in early postnatal airways. I will test this hypothesis by taking measurements of
all three parameters at specific postnatal ages (PD6, PD10, PD15, PD21, and PD28)
and will then statistically analyze the results to determine if a correlation exists.

2.2 Objective 2: Determine the effect of an acute ozone exposure
on the postnatal development and neuropeptide expression of
nodose and jugular sensory neurons.
Mounting evidence indicates that fetal and early life exposures to inhaled
environmental pollutants may play an important role in the pathogenesis of asthma seen
initially in children and later in adults. NGF concentrations in the airways can be
influenced by exposure to allergens, as well as environmental agents, such as ozone.
Both NGF administration and ozone exposure can increase the percentage of SPimmunoreactive (SP-IR) neurons in nodose and jugular ganglia. However, it has not
been determined what effects a single ozone exposure in early postnatal life may have
on sensory neuron number and the number of SP airway neurons.
Chapter 5 presents the results of trials that quantified total neuron, airway
neuron, SP neuron and SP- airway neuron number using a combination of primary
neuron culture, immunocytochemistry and flow cytometry.
In Objective 2, I hypothesize that early life ozone exposure will have no effect on
total nodose and jugular neuron number, and will increase both the number of airway
neurons and the number of SP-IR airway neurons. To test this hypothesis I will expose
PD5 aged rat pups to filtered air or 2 ppm O3 and then quantify neuron numbers on
PD10, PD15, PD21 or PD28.
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CHAPTER 3:
Epithelium Nerve Fiber Density and NGF Levels in
Early Postnatal Rat Airways

40

3.1 Introduction
Airway inflammation, a defining characteristic of asthma, is partially mediated by sensory
afferent nerve fibers innervating the airways, which exert their influence through the release of
neuropeptides from terminal arborizations (3). The majority of the sensory afferent innervation in
the airways originates in cells bodies located within vagal sensory ganglia (1, 2, 7, 21). Early
development of cell bodies in both ganglia is dependent on NGF for their growth and survival
(10, 14). Although NGF is known to influence sensory neuronal development, the role of NGF
in the development of airway innervation during early postnatal life has not been extensively
studied. One study employing transgenic mice that over-express NGF specifically in the airways
determined that, compared to wild type littermates, transgenic animals had hyperinnervated
airways (12)
NGF is a protein in the neurotrophin family (15), which acts as a target–derived or
paracrine trophic factor regulating the growth and survival of both peripheral and central
neuronal populations. Initially neurotrophins were thought to be involved exclusively in the
survival and maintenance of neuronal populations; however, it has been demonstrated that they
have a more diverse role, particularly in inflammatory conditions of neural origin (8, 9, 16). As
an inflammatory disease, the pathogenesis of asthma may involve the actions of neurotrophins
including NGF (5, 6, 18-20). Increased levels of NGF have been seen in the BALF of allergic
asthma patients following allergen challenge (23), and NGF is increased in the serum of asthma
patients (4).
The rationale for conducting this study is that if over-expression of NGF in the airways
results in hyperinnervated airways, the possibility exists that the levels of NGF present in the
airways during normal postnatal development determine the level of innervation. Neuropeptides
released from sensory afferents can mediate airway inflammation and hyperresponsiveness
through interactions with immune cells and airway smooth muscle. An increased level of
innervation heightens the possibility of increased amounts of neuropeptides present in sensory
terminals. Upon noxious stimulation of the airways, more neuropeptides could be released into
the airways, thereby exacerbating inflammation. For these reasons it is important to understand
if changes in NGF concentrations in the airway during normal postnatal development can
directly affect airway innervation levels. The objective of this study was to establish the normal
patterns of sensory innervation in the airways, along with determining how levels of NGF
change during postnatal development.
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3.2 Materials and Methods
3.2.1 Experimental Design
In order to test the hypothesis, experiments were designed to determine the nerve fiber
density in tracheal epithelium, and measure NGF protein levels in the airway from PD6 through
PD28. To assess sensory innervation in the airways, tracheal epithelium was examined on PD6,
10, 15, 21, and 28, and the nerve fiber density calculated for each respective age group. On the
same postnatal days BALF was collected to determine the NGF levels in the airway lumen.
3.2.2 Animals
Fischer 344 late gestation pregnant rats were purchased from Harlan Laboratories and
shipped while pregnant. Upon arrival pregnant females were kept in filtered ventilated cages in
a USDA-approved, specific pathogen-free and environmentally controlled animal facility. While
in the facility, animals were provided with HEPA-filtered air, autoclaved diet and tap water ad
libitum and housed under controlled light-cycle (12 hr light/ 12 hr dark) and temperature (2224°C) conditions. After pups were born they were kept in the same cage as the mother. Rat
pups were analyzed on PD6, 10, 15, 21, and 28. All procedures were done in accordance with
IACUC regulations and approved IACUC protocols.
3.2.3 Immunohistochemistry
Animals were given an overdose of sodium pentobarbital (50 mg/ml). Tracheas of
animals not receiving bronchoalveolar lavage were used for immunohistochemistry, as
described in Hunter et al., (13). Tracheas were removed by cutting caudal to the larynx and
cranial to the main bronchi. Tissues were immediately fixed in ice-cold picric-acid formaldehyde
fixative containing 2% paraformaldehyde, 15% saturated picric acid and 0.15 M phosphate
buffer (22). Three hrs later tracheas were washed twice in 0.1 M phosphate buffered saline
containing 0.3% (v/v) Triton X-100 (PBS-TX, pH=7.8). Following the second rinse, the tissue
remained in PBS-Tx overnight at 4°C. The following day, tracheas were oriented on corks so
that the first sections would be taken from the dorsal aspect of the trachea closest to the smooth
muscle side. The tissue was covered with Tissue Tek OCT (Sakura, Torrance, CA), frozen in
isopentane cooled by liquid nitrogen, placed in air tight plastic bags and stored at -80°C.
Continuous serial sections (12 µm thickness) of the trachea were collected on gelatincoated coverslips and briefly air-dried. In the smaller PD6 and 10 animals, the entire trachea
was sectioned, whereas, in the larger PD15, 21 and 28 pups, only every 4th section of trachea
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was collected. Sections were incubated with an affinity purified rabbit monoclonal antibody
against the pan neuronal marker, protein gene product 9.5 (PGP-9.5; Chemicon/Millipore,
Temecula, CA; Thompson et al., 1983) diluted 1:50 in phosphate-buffered saline, 0.3% triton X
100 and 1% (w/v) bovine serum albumin (PBS-TX-BSA) in a humidified chamber overnight at
4°C. Sections were rinsed three times with PBS-TX-BSA, for 5 min each rinse then covered with
a fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobin IgG (Jackson
ImmunoResearch, West Grove, PA), diluted 1:100 in PBS-TX-BSA and incubated at 37°C for 30
minutes. Coverslips were again rinsed three times for 5-min intervals in PBS-TX-BSA.
Fluoromount (Southern Biotechnology, Birmingham, AL) was used to mount the coverslips on
glass slides. Controls for this experiment comprised a test of the specificity of the primary
antibody in PGP-9.5-rich brain regions (positive control), or negative controls in which the
primary monoclonal antibody was omitted.
3.2.4 Nerve Fiber Density (NFD) Measurement
To measure the total NFD of the tracheal epithelium, images of PGP-9.5-containing
nerve fibers were collected in series using a Zeiss LSM 510 confocal microscope equipped with
a fluorescein filter (excitation 495 nm and emission 520 nm) and an argon laser (Zeiss,
Oberkochen, Germany). Ten sections per animal were selected randomly using standard light
microscopy to avoid bias based on innervation density. A series of twenty images representing
all of the tracheal epithelium in each section was collected, saved to a database, and exported
as black and white digital TIF images. The TIF images were analyzed using Optimas software
(Bioscan, Edmonds, WA) to determine the NFD. The perimeter of the epithelial region was
outlined digitally and PGP-9.5- immunoreactive (IR) nerve fibers were identified by
segmentation using user-defined threshold gray levels based on optimizing signal-to-noise
appearance of the nerve fibers and background. The PGP-9.5 NFD was calculated by dividing
the PGP-9.5-IR nerve fiber area by the total area of epithelium outlined.
3.2.5 Determination of Standard Lung Volume for Bronchoalveolar Lavage
Since the animals were used at different ages and the lungs were different sizes, special
procedures were developed to facilitate comparisons of BALF protein between the age groups.
A standard volume of PBS was instilled for each age group, which was determined by
measuring the volume of PBS that could be instilled into lungs at a constant filling pressure (25
cm H2O pressure). Briefly, a graduated syringe filled with a known volume PBS was attached to
tubing that was inserted into the trachea of rat pups through a small incision. The water level
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was maintained at 25 cm above the animal while the lungs were filling with the PBS. When all of
the lobes of the lungs had visibly filled, the flow of PBS was stopped and the new volume in the
syringe was recorded. The standard volume for each age group is the mean volume that was
instilled in three animals in each age group. This method was modified from a protocol for fixing
lungs for histological analysis (11). By maintaining a constant filling pressure, the conditions
used for determining the volume of PBS used for BAL procedures in different ages are uniform.
3.2.6 Bronchoalveolar Lavage Fluid Collection
BALF was collected from rat pups on PD6, 10, 15, 21, and 28. Briefly, animals were
overdosed with an i.p. injection of sodium pentobarbital (50 mg/ml), the thoracic cavity opened
and the lungs exposed. A cannula was inserted into the trachea and phosphate buffered saline
(PBS) was instilled into the lungs in situ. A standard volume of PBS was instilled for each age
group. A single bolus of PBS at the standard volume was instilled and withdrawn through the
lungs three times, collected in tubes after the 3rd withdrawl, and centrifuged at 10,000 rpm. The
supernatant was removed, aliquoted into 1.5 ml microcentrifuge tubes and stored at -80°C until
analysis was preformed.
3.2.7 NGF Enzyme-Linked Immunosorbent Assay (ELISA)
The concentration of NGF (7.8-250 pg/ml) in each lavage supernatant sample was
assayed using the NGF Emax Immuno Assay System (Promega, Madison, WI) according to the
manufacturer’s instructions. The concentration of NGF in each lavage sample was determined
using a standard curve, and then multiplied by the standard instilled volume for the respective
age group to determine the amount of NGF in the entire lung. NGF concentrations were then
normalized to the dry lung weight (g) for the respective postnatal ages (Table 3-1). All samples
were run in duplicate or triplicate, and, as a negative control, triplicate PBS samples were run
with each assay.

Table 3-1
Postnatal Age

Standard Volume Instilled (ml)

Standard Lung Dry Weight (g)

PD6
PD10
PD15
PD21
PD28

0.6 + 0.05
1.0 + 0.06
1.13 + 0.08
1.90 + 0.10
4.33 + 0.28

0.049 + 0.001
0.063 + 0.001
0.077 + 0.004
0.082 + 0.001
0.091 + 0.001

44

3.2.8 Statistical Analysis
Results of experiments are expressed as mean + SE. Nerve fiber density results are
expressed as a percentage of the area of PGP-9.5-IR nerve fibers in the total area of
epithelium. An n of 6 animals were used for all groups except were noted. All data in these
experiments were analyzed using a one-way ANOVA, followed by Tukey’s post hoc examination
when an effect was considered significant. Values were considered significant at p <0.05.

3.3 Results
3.3.1 Epithelium Nerve Fiber Density
The amount of innervation in the epithelium was measured to determine if there were
age related changes in innervation levels. Figure 3-1A shows a representative image of PGP9.5+ nerve fibers in the tracheal epithelium. The level of innervation in the tracheal epithelium at
both PD6 and PD10 was significantly increased over the NFD at PD28 (Figure 3-1B). The
decrease in NFD observed at PD21 was determined to be significantly different from the NFD at
PD10. Innervation levels did not significantly change between PD21 and PD28. Although, NFD
at PD15 appeared to be increased above PD21 and PD28 innervation levels, no significant
difference was found. Overall, the level of tracheal epithelium innervation attenuates
significantly beginning around PD15 and then stablizes.
3.3.2 NGF concentration in BALF
Next we measured levels of NGF in the BALF. NGF concentrations in the BALF of PD10
animals were significantly higher than at any other age group examined (Figure 3-2). PD15
NGF levels were slightly higher than the levels seen at PD 6, 21, and 28; however, no
significant differences were found.
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Figure 3-1. Total epithelium nerve fiber density (NFD) of postnatal day (PD) 6,10,15, 21 and 28 Rats. Nerve
fibers in the epithelium were identified using PGP-9.5 immunohistochemistry and quantified. Quantifications
were done using Optimas Imaging software. (A) Representative confocal image of airway from PD 10 rat
pup. Arrows indicate PGP-9.5+ positive nerve fibers. E: epithelium; LP: lamina propria; SM: smooth muscle.
(B) NFD is expressed as percent area and numbers represent the average of all animals sampled for a
particular age group. The epithelium NFD in PD6 and PD10 animals were significantly higher than in PD28
rats (*p<0.05). PD10 NFD was also significantly increased above PD21 levels (#p<0.05). No difference was
seen in PD15 rats. Numbers in parenthesis represent the n value for each age group.
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Figure 3-2(5)
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Figure 3-2. Nerve growth factor (NGF) protein concentration in bronchoalveolar lavage fluid (BALF) of
postnatal day (PD) 6, 10, 15, 21 and 28 Rats. Lavage fluid was collected from animals and NGF protein
levels were quantified according to manufacturer’s specifications using the NGF Emax Immuno Assay
System (Promega, Madison, WI). Protein levels are expressed in pg/g lung. PD10 animals had significantly
increased NGF levels over all other age groups. .(*p<0.05). Numbers in parenthesis represent the n value for
each age group.
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Figure 3-3. Nerve growth factor (NGF) protein concentration in bronchoalveolar lavage fluid (BALF)
compared with epithelium nerve fiber density (NFD) of postnatal day (PD) 6, 10, 15, 21 and 28 rats. Both
NGF levels in BALF (bars) and epithelium NFD (line) are maximally increased on PD10.
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3.4 Discussion
The results of this study reveal that the levels of NGF in lavage fluid on PD10 were
significantly greater than levels measured on any other day. Epithelium NFD was also greatest
on PD10 and was significantly greater than the NFD measured in both PD21 and PD28 rat
pups. PD6 rats had epithelium NFD levels that were significantly greater than NFD levels
measured on PD28. Given the known effects of NGF on axonal growth, these findings suggest
that a relationship exists between epithelium NFD and the levels of NGF measured in BALF
during normal postnatal development.
In a study examining NGF levels in postnatal aged mice Lommatzsch et al., reported
NGF concentrations measured in mouse whole lung homogenates during normal postnatal
development decrease between PD1 and PD21 (17). We determined that the levels of NGF
were significantly higher at PD10 than at any other day examined, and that NGF levels
remained low after PD21 (Figure 3-2). Although our study looked at a more specific timeline,
both studies describe decreased levels of NGF at PD21 that remained low at later time points.
A study conducted by Hoyle et al. (12) using transgenic mice that over-express NGF
specifically in the lung found that the airways of the transgenic mice were hyperinnervated when
compared to wild type. In our study, the changes occurring in both parameters followed a similar
pattern, however, statistical analysis using a Pearson correlation revealed that epithelium NFD
and NGF levels in lavage fluid did not correlate (r2=0.5531). This discrepancy could be due to
trophic support from within the epithelium itself that cannot be measured in the BALF, for
instance, if it had not been released into the lumen. It is likely that the axons arborize upon
reaching the epithelium and that this innervation might change as animals age or as targetderived trophic support is altered. Another possible variable is that the effect of elevated NGF
may be delayed if it take a few days for axonal branching to reach their maximal level of growth.
3.4.1 Conclusions
While the correlation statistics do not indicate that the levels of NGF in the airways
directly determine the extent of epithelium innervation, it is hard to ignore the similar pattern that
epithelium NFD and NGF levels in BALF follow of both being maximally increased on PD10 and
then decreasing from PD15 through PD28. When the two parameters are graphed together as
shown in Figure 3-3, a potential relationship between the two emerges. If an increase in NGF
levels measured at an earlier age were followed by an increase in NFD levels at a subsequent
age, then a more direct relationship between the two might be elucidated. However, NGF levels
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and airway innervation being significantly increased on the same day demonstrates that, while
NGF may not be the only determining factor in airway innervation levels, NGF a likely modulator
of airway epithelial nerve fiber development in early postnatal life.
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CHAPTER 4:
Preliminary Neuron Studies

53

4.1 Introduction
Sensory innervation of the airways has been extensively investigated in many species.
It is known that sensory afferent fibers in the respiratory tract have an important role in
regulating inflammation and airway responsiveness in both physiologic and pathologic states.
Although several studies have been conducted to examine changes in neuron numbers in the
nodose and jugular ganglia, the soma responsible for the majority of sensory afferent
innervation in the airways, those studies have been primarily conducted in adult animals and
have focused more on changes in the neuropeptide content than on changes in neuron number.
Work conducted by Bakal and Wright (1) looking at postnatal development of nodose
neurons has shown that the number of neurons in the nodose ganglia of rats decreases until
approximately PD15. Studies done by Cooper (3) found that in rats, nodose ganglion neuron
number did not change during postnatal development. The lack of consensus on neuron
number combined with the fact that these studies did not evaluate specific subsets of neurons,
such as those projecting to the airway, and they did not examine changes in neuron numbers in
the jugular ganglia, indicated that further investigation is warranted.
A series of preliminary assessments were undertaken to ascertain the most effective
way to quantify neurons in the nodose and jugular ganglia. Two different quantification methods
were used, i.e., design-based stereology and flow cytometry. The first experiments used designbased stereology to count neurons by hand, in fixed sections of ganglia; however, findings from
this initial work indicated possible methodological limitations in this approach. To address these
possible issues, a second group of experiments was conducted to evaluate if flow cytometry
would be a valid technique for counting dissociated nodose and jugular ganglia neurons.
Results of these studies showed a very large, unexpected increase in total neuron number
between PD15 and PD28. In order to elucidate the cause of this increase in neuronal number, a
third set of experiments sought to determine if the large changes in neuron numbers analyzed
using flow cytometry were due to nodose and jugular ganglia neuron proliferation. These
studies used two different thymidine analogs, bromo-deoxyuridine (BrdU) and 5-Ethynyl-2'deoxyuridine (EdU), which are incorporated into DNA during the active DNA synthesis occurring
in proliferating cells. The first assessment of neuron proliferation using BrdU showed possible
neuron proliferation; however, no definitive conclusions could be made due to the extensive
tissue damage that occurred during the detection process. EdU was used in the second
assessment of neuron proliferation, and EdU fluorescence was not detected in any neurons in
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the nodose or jugular ganglia. It was, therefore, concluded that neuron proliferation did not
explain the large increase in neuronal number. The final set of trials used flow cytometry as the
quantification technique, however new staining protocols were employed to determine if the
variability seen in the previous flow cytometry experiments could be minimized. The objectives
of this study were to 1) determine the most effective method for quantification of nodose and
jugular ganglia neurons, 2) determine if increases in neuron numbers observed in preliminary
experiments are the result of neuron proliferation and to 3) optimize flow cytometry techniques
used for the analysis of neuron numbers.

4.2 Materials and Methods
4.2.1 Experimental Design
4.2.1a Nodose and Jugular Airway Neuron Counts:
In order to establish a time course of airway sensory neuronal development, retrograde
tracing was used to identify neurons in the nodose and jugular ganglia that specifically innervate
the trachea epithelium. Fluorescent RetroBeads™ (beads, LumaFluor Inc., Durham, NC) are
not cytotoxic, persist for long periods in retrogradely-labeled soma, do not transverse the
basement membrane, and are compatible with immunocytochemical techniques (2, 6, 7). The
beads were instilled into the tracheal lumen of all animals on PD2. All animals received bead
instillations on the same day so that microspheres would be present in the airways throughout
the time course of this study, and as a control for size variations between animals as they age.
For preliminary stereology studies pups were euthanized on PD6, PD10, PD15, PD28,
and PD60. Ganglia were removed, fixed, frozen, sectioned, and counterstained with the nuclear
stain 4’6-diamindio-2-phenylindole (DAPI). The number of airway neurons contained in the
nodose and jugular ganglia was quantified through analysis using fluorescent microscopy in
conjunction with Stereo Investigator software.
Preliminary studies performed using flow cytometry were conducted. Bead instillations
were completed in the same manner as animals used for neuron quantification with stereology.
Ganglia were excised, disassociated, and processed for flow cytometry. Animals were analyzed
on PD6, PD10, PD15, and PD28. The total number of neurons in nodose and jugular ganglia
and the number of airway neurons in both ganglia were quantified.
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4.2.1b BrdU and EdU Experiments:
To determine if neuron proliferation is occurring in nodose and jugular ganglia, BrdU and
EdU studies were undertaken. BrdU and EdU are nucleoside analogs of thymidine that when
available in cells, are incorporated into the DNA of proliferating cells during S-phase. Any BrdU
that is incorporated into DNA can then be detected using an anti-BrdU antibody. EdU DNA
incorporation is detected via a copper-catalyzed covalent reaction between an azide and an
alkyne. BrdU or EdU was administered via single intraperitoneal injection on PD22, PD24, and
PD26. All animals were euthanized on PD28; nodose and jugular ganglia were removed, fixed,
frozen, and prepared for BrdU / EdU detection. Immunohistochemistry for the pan neuronal
marker, PGP-9.5, was performed in addition to BrdU / EdU detection. Sections of ganglia
processed for PGP-9.5 and BrdU or EdU were visualized on a fluorescent microscope capable
of detecting FITC, Rhodamine, and Alexa Fluor 647.

4.2.2 Animals
Late gestation pregnant female Fischer 344 rats were purchased from Harlan
Laboratories and shipped while pregnant. Upon arrival pregnant females were kept in filtered
ventilated cages in a USDA-approved, specific pathogen-free and environmentally controlled
animal facility. While in the vivarium, animals were provided with HEPA-filtered air, autoclaved
diet and tap water ad libitum and housed under controlled light-cycle (12 hr light/ 12 hr dark) and
temperature (22-24°C) conditions. After pups were born they were kept in the same cage as the
mother. Rat pups were analyzed on PD28. All procedures were done in accordance with IACUC
regulations and approved IACUC protocols.

4.2.3 Fluorescent Microsphere Instillation
Retrograde tracers were instilled into the tracheal lumen in order to identify sensory
neurons in the nodose and jugular ganglia that specifically innervate the airway epithelium.
Briefly, on PD2, rat pups were anesthetized via ice immersion-induced hypothermia (3-5 min).
The pups were placed inside a latex sleeve, to protect their skin. When sufficiently anesthetized,
the trachea was exposed with a midline incision in the skin on the ventral surface of the neck.
Next, for stereology studies, 2 µl of a mixture of Green and Red Fluorescent beads were
instilled into the tracheal lumen using a 10 µl Hamilton syringe. For flow cytometry studies only
green beads were used, as the flow cytometer was not equipped with the appropriate laser filter
combination to detect the red beads. Incisions were closed using surgical glue. Rat pups were
revived using gentle warming and artificially ventilated if needed. When animals regained
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consciousness and were breathing normally, they were returned to their mother. As the beads
need a minimum of four days to travel from the epithelium to the cell body and since the beads
reach maximal uptake within seven days of instillation (6), animals were not examined prior to
PD6.

4.2.4 Stereology
4.2.4a Sample Preparation
On PD6, 10, 15, 28 or 60, animals were euthanized with an i.p. injection of sodium
pentobarbital (50 mg/ml), both vagus nerves were exposed and the left and right vagal ganglia
were removed, as described in, Hunter et al. (5). Tissues were immediately fixed in ice-cold
picric-acid formaldehyde fixative containing 2% paraformaldehyde, 15% saturated picric acid
and 0.15 M phosphate buffer (9). Three hours later ganglia were washed twice in 0.1 M
phosphate buffered saline containing 0.3% (v/v) Triton X-100 (PBS-TX, pH=7.8). Following the
second rinse, the tissue remained in PBS-TX overnight at 4°C. The following day, ganglia were
oriented on corks in parallel alternated positions, with one ganglia rotated 180°. The tissue was
covered with Tissue Tek OCT (Sakura, Torrance, CA), frozen in isopentane cooled by liquid
nitrogen, placed in airtight plastic bags and stored at -80°C.
Continuous serial sections (2 5µm thickness) of the ganglia were collected on gelatincoated cover slips and briefly air-dried; every section of ganglia was collected. Following section
collection slips were then mounted onto slides using ProLong® Gold antifade with DAPI
(Invitrogen, Carlsbad, CA). Slides were allowed to cure overnight and were then sealed with
clear nail polish before being analyzed.
4.2.4b Analysis: Airway Neuron Counts
Using Stereo Investigator software (MBF Bioscience, Williston, VT), sensory neurons in
the nodose and jugular whose axons specifically innervate the tracheal epithelium can be
identified. Briefly, at low magnification sections are defined as regions of interest, then at higher
magnification airway neurons are distinguished from other neurons if they contain red or green
beads. A feature of the software called Meander Scanning is used to ensure that neurons are
only counted once. The meander scan moves the motorized microscope stage to a new area of
the region of interest. Airway neurons are then identified and labeled using a marker (Figure 41).

57

4.2.5 BrdU or EdU Injections
BrdU or EdU injections were used to determine if cell proliferation was occurring in the
nodose and jugular ganglia between PDs 21 and 28. Briefly, on PDs 22, 24 and 26 animals
were placed in a restraint of known mass and then weighed to determine animal weight. BrdU
(Zymed Laboratories, San Francisco, CA), EdU (Molecular Probes / Invitrogen, Carlsbad, CA)
or PBS was administered intraperitoneally (i.p), at a concentration of 1 ml/100 g body weight,
with the appropriate dose being determined from body weight measurement on each day.
Weight measurements and injections occurred at the same time each day.

4.2.6 Immunohistochemistry
Ganglia were excised and prepared for immunohistochemical studies as described in the
“Stereology Sample Preparation” section. Continuous serial sections (12 µm thickness) of the
ganglia were collected on gelatin-coated cover slips and briefly air-dried, and every 4th section
of ganglia was collected. In an attempt to increase section adherence to cover slips, sections
fixed to slides using an acetone / methanol mixture (1:1), for 10 min at 4°C and then allowed to
air-dry at 37°C for 30 min. After drying, sections were incubated with an affinity purified rabbit
monoclonal antibody against diluted 1:50 in PBS-TX + 1% (w/v) bovine serum albumin (PBSTX-BSA) in a humidified chamber overnight at 4°C. Sections were rinsed three times with PBSTX-BSA, for 5 min each rinse then covered with a rhodamine-conjugated goat anti-rabbit
immunoglobin IgG (Jackson ImmunoResearch, West Grove, PA), diluted 1:100 in PBS-TX-BSA
and incubated at 37°C for 30 min. Cover slips were again rinsed three times for 5-min intervals
in PBS-TX-BSA. Cover slips were then processed for BrdU detection.
In EdU assays, EdU detection was performed prior to immunohistochemistry for PGP9.5. To allow for visualization of EdU conjugated to Alexa Fluor® 647, a FITC-conjugated goat
anti-rabbit secondary antibody (Jackson ImmunoResearch, West Grove, PA) was used to detect
PGP-9.5, rather than a rhodamine conjugated secondary antibody. Controls for this experiment
comprised a test of the specificity of the primary antibody in PGP-9.5 rich brain regions (positive
control), or negative controls in which the primary monoclonal antibody was omitted.
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4.2.7 Flow Cytometry
4.2.7a Nodose and Jugular Ganglia Neuron Isolation
At PD 10, 15, 21, or 28 pups were euthanized with an i.p. injection of sodium
pentobarbital (50 mg/ml), both vagus nerves were exposed and the left and right nodose and
jugular ganglia were removed. Neurons were isolated using a method previously described by
Kwong and Lee (8). Briefly, following removal, ganglia were desheathed, cut into smaller pieces
and placed in a 0.125% collagenase type IV in Dulbecco’s Modified Eagle Medium: Nutrient
Mixture F12 (DMEM/F12) media solution overnight at 37°C. To terminate collagenase activity,
the suspension was pelleted (150g, 5 min) and resuspended in a solution of 0.15% trypsin
EDTA in Hank’s Balanced Salt Solution (HBSS) (<1 min) repelleted (150g, 5 min) and
resuspended in modified DMEM/F12 solution. This final suspension, containing a mixture of
cells and cellular connective tissue fragments was layered on top of a solution of 15% bovine
serum albumin (BSA) in DMEM/F12. Subsequent centrifugation (500g, 8 min) through the BSA
solution resulted in the trapping of myelinated debris such that the remaining pellet contained
mostly neurons free of cellular and connective tissue fragments. The pelleted neurons were
collected and then prepared for flow cytometry.
4.2.7b Staining and Analysis
Cell pellets containing isolated neurons were resuspended in 500 µl of DMEM/F12
media with 250 µl of BD Cytofix/Cytoperm Kit (BD Biosciences, San Jose, CA) for 20 minutes to
fix and permeabilize them. Cells were incubated with a guinea pig primary antibody
(Chemicon/Millipore, Temecula, CA) against PGP-9.5 for 30 min at 4°C. After incubation, cells
were washed twice to remove any unbound primary antibody, followed by the addition of a RPhycoerythrin (RPE) conjugated donkey anti-guinea pig antibody (Jackson ImmunoResearch,
West Grove, PA). Cells were incubated with the secondary antibody for 30 min at 4°C, then
washed twice to remove any unbound antibody, and resuspended in a final volume of 300 µl.
Prior to analysis, samples were passed through a 70µm cell strainer to remove cellular debris.
Cells were analyzed on a BD FACSAria (BD Biosciences, San Jose, CA) located in the WVU
Flow Cytometry Core Facility using DIVA 6.1 software. For each sample, data was collected
using a constant flow rate for 60 seconds. Events were deemed neurons if they were PGP-9.5
positive and their size and amount of cellular granulation were consistent with the
characteristics of neurons. Neurons that innervate the airways were identified as being FITC
positive as an indicator of the retrograde transport of green beads.
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To calculate the number of neurons in each sample the following equation was used:

Number of Events
Volume Sampled

=

Neuron Number
Total Sample Volume

For each sample set analyzed, a tube containing a known volume of buffer was run
through the FACSAria for the same time and at the same flow rate used for sample analysis.
The volume sampled was determined by measuring the amount remaining in the tube.
4.2.7c DAPI Counterstaining
In experiments that utilized the new staining protocol neuronal isolates were incubated
with DAPI (1:5000) for ten minutes at 4°C following immunohcytochemical staining for PGP-9.5.
Cells were then washed, filtered through a 70 µm cell strainer, and resuspended in a final
volume of 300 µl. An event was considered an intact cell if it was DAPI positive.

4.2.8 Cell Proliferation Detection
4.2.8a BrdU Detection
In order to detect BrdU incorporation in nodose and jugular neurons, the Zymed BrdU
Staining Kit (Zymed Laboratories, San Francisco, CA) was used. This kit employs a biotinylated
monoclonal anti-BrdU for detection and the presence of BrdU is revealed using a highly
sensitive streptavidin-biotin staining system. BrdU was detected in accordance with
manufacturer instructions. Briefly, following immunohistochemical detection of PGP-9.5,
sections were treated with 0.3% hydrogen peroxide to quench endogenous peroxidase activity.
Sections were then treated with trypsin and a denaturing solution in order to increase the
permeability of sections, thereby enhancing antibody penetration. After rinses with PBS,
sections were blocked with a blocking solution to minimize non-specific binding. After rinsing,
sections were then incubated with a biotinylated mouse-anti-BrdU antibody at room temperature
for 60 min. Slides were rinsed in PBS, and then incubated with a streptavidin-FITC conjugated
secondary antibody for 60 min at room temperature. Sections were rinsed again in PBS to
remove any unbound antibody, and then Fluoromount (Southern Biotechnology, Birmingham,
AL) was used to adhere cover slips to the slides, in order to preserve the fluorescence. Both
positive and negative control sections were included in the study. Sections of gut from animals
receiving BrdU injections, and those receiving PBS injections, were processed simultaneously
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with ganglia sections. Gut was used because of the high proliferation rates of intestinal
epithelial cells. Slides were protected from light and stored at 4°C until visualized on the
microscope. Images were taken using a LSM510 confocal microscope equipped with the
appropriate laser / filter combinations to allow for visualization of both FITC and rhodamine.
4.2.8b EdU Detection
EdU incorporation was detected using the Click-iT® EdU Imaging Kit (Molecular Probes
/ Invitrogen, Carlsbad, CA). This kit uses a copper-catalyzed covalent reaction between an
azide and an alkyne for EdU detection. In this application, the EdU contains the alkyne and the
Alexa Fluor® 647 dye contains the azide. EdU detection was performed in accordance with
manufacturer instructions. Briefly, following sectioning and collection of samples on gelatincoated cover slips, sections were incubated with the Click-iT® reaction cocktail (containing
copper sulfate and Alexa Fluor® azide component) for 30 min at room temperature in an
opaque humidified chamber to protect sections from the light. Cover slips were washed with
PBS containing 3% BSA. Cover slips were then processed for immunohistochemical detection
of PGP-9.5 and mounted onto slides using Fluoromount (Southern Biotechnology, Birmingham,
AL). Both positive and negative control sections were included in the study. Sections of gut
from animals receiving EdU injections, and those receiving PBS injections were processed
simultaneously with ganglia sections. Sections of ganglia that were processed without adding
the Alexa Flour 647 azide, and ganglia sections from animals receiving PBS in vivo were also
done. Slides were protected from light and stored at 4°C until visualized on the microscope.
Images were taken using a LSM510 Confocal microscope equipped with the appropriate laser /
filter combinations to allow for visualization of both FITC and Alexa Flour 647.

4.2.9 Statistical Analysis
Results of stereology experiments are expressed as means. Results of flow cytometry
experiments are expressed as means + SEM. An n of 6 animals was used for all groups except
where noted. All data in these experiments were analyzed using a one-way ANOVA, followed by
Tukey’s post hoc examination when an effect was considered significant. Values were
considered significant at a p-value < 0.05.
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4.3 Results
4.3.1 Neuron Counts
4.3.1a Airway Neuron Counts: Stereology
Airway neurons were counted to determine if age-related changes in neuron number
exist in this subpopulation of nodose and jugular ganglia neurons. Figure 4-2A shows a
representative image of nodose and jugular ganglia section that is positively stained for DAPI,
while 4-2B is a representative image of cell bodies in the nodose and jugular ganglia containing
retrogradely transported beads from the airways. The number of airway neurons in PD6 animals
262 + 13 (n=3) was significantly different from all other age groups (Figure 4-2C). PD10 rat
pups had 153 +12 (n=5) labeled airway neurons, where as the numbers of airway neurons in
PD15, 28 and 60 were 130 + 10.6, 104 + 8 (n=2), and 107 + 8 (n=2), respectively. No other
statistical differences were noted. These studies indicate that as animals age the number of
neurons specifically innervating the airway decreases.
4.3.1b Neuron Counts: Flow Cytometry without DAPI counter-staining
Using flow cytometry without DAPI counter-staining it was determined that airway
neuron numbers in PD28 2,334 + 468 (n=13) animals were significantly different from neuron
numbers in PD10 722 + 197 (n=10) and PD15 913 + 177 (n=7) rats (Figure 4-3A). Airway
neuron numbers in PD6 rats 1,050 + 208 (n=8) were not significantly different from neuron
numbers in any other age groups. The number of total neurons in PD28 rat pups 165,678 +
53,570 (n=13) was significantly different from neuron numbers in PD6 12,485 + 2,194 (n=8)
animals (Figure 4-3B). PD10 rats had 42,979 + 5,636 (n=7) total neurons, whereas PD15
animals had 69,829 + 16,858 (n=10) total nodose and jugular ganglia neurons. No other
significant differences were found. While neuron numbers in PD15 and PD28 rats were not
significantly different, the large increase in neuron numbers between the two age groups was
unexpected and so studies to determine why such an increase was seen were conducted.

4.3.2 Cell Proliferation Studies
4.3.2a BrdU Detection
In order to establish if increases in total nodose and jugular neuron numbers between
PD12 and PD28 were due to neuron proliferation, BrdU studies were performed. Figure 4-4 (A
and B) shows representative images of sections of gut from animals administered BrdU in vivo
(A) and those receiving PBS in vivo (B). Images of PGP-9.5 and BrdU staining in nodose and
jugular ganglia are shown in Figure 4-4C and D. Extensive tissue degradation made
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confirmation of BrdU staining in neurons impossible, so a second study to look for proliferation
in the nodose and jugular ganglia was undertaken.
4.3.2b EdU Detection
In an attempt to determine if nodose and jugular ganglia neurons are proliferating
between PD15 and PD28, EdU studies were conducted. Representative images from EdU
experiments are shown in Figure 4-5. Figure 4-5A shows gut from an animal that was
administered PBS in vivo and 4-5B is gut from an animal receiving EdU in vivo. Images of
ganglia from a rat administered EdU in vivo (Alexa Flour 647 not included in Click-iT® reaction
cocktail) and a rat receiving PBS in vivo are shown in Figure 4-5 C and D, respectively. A
ganglia section from a rat administered EdU in vivo and stained for PGP-9.5 is shown in Figure
4-5E. Observations of images collected from animals administered EdU in vivo revealed no
EdU staining in nodose or jugular ganglia neurons and it was, therefore, concluded that
neuronal proliferation was not the cause for the large increase in neuron number between PD15
and PD28.

4.3.3 Neuron Counts: Flow Cytometry (new staining protocol)
As no EdU staining was visualized in nodose and jugular ganglia neurons, amended
staining protocols for the flow cytometer assay were attempted. It was decided to counterstain
all neuronal isolates with DAPI to identify nuclei in cells. Whole cells were deemed neurons if
they were both DAPI positive PGP-9.5 positive. Neurons that innervate the airways were
identified as being FITC positive as an indicator of the retrograde transport of green beads.
Statistical analysis to determine if differences existed between the two staining protocols
was not performed, however, total nodose and jugular ganglia neuron numbers measured in
DAPI stained samples were substantially lower than neuron numbers measured in samples not
stained with DAPI (Table 4-1). Based on these results, it was determined that neuron counts
would be conducted employing flow cytometry for determination of nodose and jugular neuron
number, and all future studies would use DAPI counterstaining.
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Table 4-1

Table 4-1. Comparison of Staining Protocols: with DAPI vs. without DAPI
PD6

PD10

PD15

PD28

PGP-9.5+/DAPI+

83

429

344

453

PGP-9.5+/DAPI-

1051

914

723

2334

PGP-9.5+/DAPI+

924

8197

12435

6765

PGP-9.5+/DAPI-

12496

42979

69830

165679

Airway Neuron Number

Total Neuron Number
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Figure 4-1 (7)

Meander Scanning

Labeled
Airway
Neurons

Figure 4-1. Visual representation of meander scanning technique for airway neuron counts.
A section of nodose and jugular ganglia is visualized on the microscope at 10x
magnification. A tracing of the entire section is drawn, identifying the ganglia as the region of
interest (ROI). At 40x airway neurons were identified as containing red or green beads. The
meander scan feature of the software overlays a grid on the ROI, and then the motorized
stage of the microscope moves within the grid to a new area on the ROI, until all areas of the
grid have been counted.
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Figure 4-2 (8)
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Figure 4-2. Number of airway neurons contained in nodose and jugular ganglia of postnatal day (PD) 6,10,15, 28
and 60 rats as determined by stereology. (A) Representative image of nodose and jugular ganglia nuclei stained
with DAPI. (B) Representative image of neurons labeled with fluorescent microspheres retrogradely transported
from the airway. (C) A one-way ANOVA followed by Tukey’s post-hoc examination found that airway neuron
numbers in PD6 animals were significantly higher than in PD10, PD15, PD28 and PD60 animals (* p<0.05).
Neuron numbers represent the average of all animals sampled for a particular age group. Numbers in
parenthesis represent the n value for each age group.
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Figure 4-3. Number of total and airway neurons contained in nodose and jugular ganglia of postnatal day
(PD) 6,10,15 and 28 rats as determined by flow cytometry. (A) Total neuron numbers in PD28 rat pups were
significantly different from neuron numbers in PD6 animals. No other significant differences were found. (B)
Airway neuron numbers in PD28 animals were significantly different from neuron numbers in PD10 and PD15
rats. Airway neuron numbers in PD6 rats were not significantly different from neuron numbers in any other
age groups. Numbers in parenthesis represent the n value for each age group. *p <0.05
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Figure 4-4 (10)
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Figure 4-4. BrdU cell proliferation studies. (A) Representative image of gut section from a rat administered BrdU
(red) in vivo and immunohistochemically stained for PGP-9.5 (green). (B) Representative image of gut section
from animal receiving PBS in vivo and immunohistochemically stained for PGP-9.5 (green). (C-D) Representative
Images of PGP-9.5 (green) and BrdU (red) staining in nodose and jugular ganglia.
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Figure 4-5 (11)
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Figure 4-5. EdU cell proliferation studies. (A) Representative image of gut from an animal administered PBS in
vivo. (B) Representative image of gut from an animal receiving EdU in vivo. (C) Representative image of nodose
and jugular ganglia from rat receiving PBS in vivo. (D) Image of nodose and jugular ganglia from a rat
administered EdU in vivo (Alexa Flour 647 not included in Click-iT® reaction cocktail). (E) Representative image
of nodose and jugular ganglia section from a rat administered EdU (red) in vivo and immunohistochemically
stained for PGP-9.5 (green).
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4.4 Discussion
The results of this series of preliminary assessments indicated that analysis with flow
cytometry was a more efficient assay to use than stereology for determining neuron number in
the nodose and jugular ganglia. It was also determined that neuron proliferation does not
account for increases in neuron number observed during late postnatal development (between
PD15 and PD28), and that DAPI counterstaining is an effective technique to decrease variability
in neuron counts performed using flow cytometry.

4.4.1 Neuron Counts
4.4.1a Airway Neuron Counts: Stereology
Neuron counts for these studies were initially conducted using fixed, frozen tissue
sections because previously conducted studies that aimed to determine neuron number in the
nodose ganglia did so using tissue sections. Stereological analysis was chosen in order to
decrease bias in counts, and the Stereo Investigator software package “Meander Scanning” tool
was used for counting airway neurons in nodose and jugular ganglia (Figure 4-1). Meander
scanning allowed for the counting of labeled airway neurons across multiple sections without
recounting the same neuron that might appear in several sections. The optimal section
thickness for sections used for airway neuron counts was determined to be 25 µm because it
allowed the user to count neurons in multiple focal planes in the shortest amount of time.
Though beads are clearly visible at high magnifications and are easily captured in images,
photobleaching was a concern. Meander scanning must be done in real time and, therefore,
sections were exposed for long periods of time, which could result in counting few labeled
neurons than are actually present. In addition, the sections used for airway neuron counts were
also to be used for total neuron counts, and photobleaching of the DAPI counterstaining was a
possible issue (Figure 4-2).
Another possible problem with using stereology as the counting method for nodose and
jugular neurons was that the optimal section thickness needed for counting total neuron
numbers was 35 µm or greater. As previously discussed above, the optimal section thickness
for airway neurons was < 30 µm. Due to this difference in section thickness, additional sets of
animals would have been required to complete total neuron counts.
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4.4.1b Neuron Counts: Flow Cytometry
Investigation of the literature revealed that flow cytometry had previously been employed
to count embryonic dorsal root ganglion neurons, though the application was different than what
was used for the studies described in this work. Neuron dissociation techniques used in single
cell electrophysiology recording experiments (8) demonstrated that nodose and jugular ganglia
neurons could be isolated and individually identified. By moderately adapting this approach,
nodose and jugular neurons were isolated and processed for analysis by flow cytometry.
Initial experiments using flow cytometry for neuron counts found that this method of
examination reduced the possibility of human bias to nearly zero, as well as having a higher
throughput of sample analysis than stereology trials. While flow cytometry proved to be the
more rapid counting method, two concerns arose during the optimization process. The first
issue was the very sizeable, unexpected increase in neuron number between PD15 and PD28
(Figure 4-3B). The second was that the small proportion of airway neurons to total neurons
made detection of labeled airway neurons challenging. Since previous studies examining
neuron number in the nodose ganglion were not in agreement as to the pattern of normal
postnatal neuron development in the ganglion, studies to determine if neuron proliferation was
the cause of the increase were conducted.

4.4.2 Cell Proliferation Studies
Several theories arose to explain why there was such a large increase in neuron
number. Older animals have larger nodose and jugular ganglia than younger animals, and it
was reasoned that the size increased was not due to and increase in connective tissue alone.
Also since the airways are growing during this same time period, more sensory neural input is
required, and as a result more neurons are need to meet the increased demand. Further
evidence for the possibility of neuronal proliferation came from a study by Czaja et al. (4) in
which it was found that following capsaicin-induced neuronal death, new nodose ganglion
neurons developed. A similar mechanism might be involved during normal airway sensory
neural development, in order to meet the innervation demands of growing airways.
4.4.2a BrdU
BrdU incorporation was initially used to address the first concern that neuron
proliferation was a possible cause of the large increase in total neuron number between PD15
and PD28. BrdU was administered at the same time every other day starting on PD22, in an
attempt to ensure that the thymidine analog would be present in a high enough concentration to
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be incorporated into proliferating cells. This technique, however, proved inconclusive due to the
extensive tissue damage that occurred during the detection process (Figure 4-4).
4.4.2b EdU
An alternative thymidine analog that employed a more mild detection process was
evaluated in an effort to determine if nodose and jugular ganglion neurons were undergoing
mitosis. EdU administration was conducted in the same manner that was used for BrdU
administration. The different detection technique used for EdU detection was much less
destructive to tissue sections, allowing for the collection of sufficient data to conclude that
neuron proliferation was not occurring in nodose and jugular ganglia neurons between PD21
and PD28 (Figure 4-5). Having addressed concerns that neuron proliferation was occurring, the
next task was to determine if the flow cytometry technique could be further enhanced to
optimize detection of airway neurons as well as elucidate a potential cause for the increase in
neuronal number.

4.4.3 Neuron Counts: Flow Cytometry (new staining protocol)
It was decided that a simple yet effective solution to both concerns raised from initial flow
cytometry experiments would be to label the nuclei of all cells by counterstaining with DAPI.
DAPI staining provided an additional parameter for the identification of neurons in that now only
the population of cells having an intact nucleus would be further examined for the presence of
the neuronal marker PGP-9.5. From the population of DAPI+PGP+ neurons, the neurons
containing beads were much more easily detected because the total population of neurons was
now clearly defined, and substantially smaller than the population of total neurons determined
during initial flow cytometry experiments (Table 4-1).

4.4.4 Conclusions
These preliminary analyses were successful in indentifying the most effective method for
determining neuron number in the nodose and jugular ganglia. Though stereology is a powerful
and effective tool that would allow for morphological information to be collected during the
process of counting neurons, it was shown to be less efficient than flow cytometry. Employing
the flow cytometry assay virtually eliminated all human bias from neuron counts, increased
sample throughput, decreased variability in results and allowed for counting total and airway
neurons within the same animal. It was for those reasons that flow cytometry was chosen for all
future analysis of nodose and jugular neuron number.
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5.1 Abstract
Sensory neurons originating in nodose and jugular ganglia that innervate airway epithelium
(airway neurons) play a role in inflammation observed following exposure to inhaled
environmental irritants such as ozone (O 3). Airway neurons can mediate airway inflammation
through release of the neuropeptide substance P (SP). While susceptibility to airway irritants is
increased in early life, the developmental dynamics of afferent airway neurons are not well
characterized. The hypothesis of this study was that airway neuron number might increase with
increasing age, and that an acute, early postnatal O3 exposure might increase both the number
of sensory airway neurons as well as the number SP–containing airway neurons. Studies using
Fischer 344 rat pups were conducted to determine if age or acute O3 exposure might alter
airway neuron number. Airway neurons in nodose and jugular ganglia were retrogradely
labeled, removed, dissociated, and counted by means of a novel technique employing flow
cytometry. In Study 1, neuron counts were conducted on postnatal days (PD) 6, 10, 15, 21, and
28. Numbers of total and airway neurons increased significantly between PD6 and PD10, then
generally stabilized. In Study 2, animals were exposed to O 3 (2 ppm) or filtered air (FA) on PD5
and neurons were counted on PD10, 15, 21, and 28. O 3 exposed animals displayed significantly
less total neurons on PD21 than FA controls. This study shows that age-related changes in
neuron number occur, and that an acute, early postnatal O 3 exposure significantly alters
sensory neuron development.
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5.2 Introduction
Sensory innervation in the airways is important in the pathogenesis of inflammation
associated with asthma and other obstructive respiratory disorders (2, 19, 23). However, a few
studies have been undertaken to describe the dynamics and development of airway innervation
during early postnatal lung development. Furthermore, the lung continues to grow and develop
throughout childhood (7) and early childhood is recognized as highly sensitive to the effects of
airway irritants, including allergens, cigarette smoke and air pollutants (26).
There are several components of postnatal airway development that contribute to normal
sensory innervation. One component originates from the sensory neurons in the nodose and
jugular ganglia. These ganglia are largely responsible for the sensory innervation in the thoracic
and abdominal viscera, including the heart, lung, and GI tract. Nerve tracing studies
demonstrated that airway afferent fibers contain cell bodies located in the nodose and jugular
ganglia (5, 11, 14) whose projections include nociceptive C-fibers that mediate airway
inflammation through the release of the neuropeptide, SP (8, 15, 22).
Many airway environmental irritants including cigarette smoke, allergens and ozone (O3)
may affect the extent of neuropeptide expression in the airways (6, 13, 17, 18) and early life
may be a particularly susceptible period. Hunter et al. (12) found that rats exposed to O3 during
early postnatal life (between postnatal days 2-6), and then re-exposed to O3 later in life
(postnatal day 28), have increased SP innervation compared to rats exposed only on PD28.
However, the underlying mechanism generating this altered neural response to early-life O3
exposure has not been established.
This investigation examined the possibility that neuron number changes in an agespecific manner and that O3 exposures in early life increase the number of airway neurons as
well as raising the number of SP-containing neurons in the nodose and jugular ganglia that
innervate the airway. The approach involves a novel technique combining neural tracing of
airway neurons, enzymatic dissociation of the nodose and jugular ganglia, and high-throughput
cell quantification.
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Experimental Design
In order to test the hypothesis, experiments were designed to quantify the number of
neurons in the nodose and jugular ganglia innervating the airway epithelium that contain SP.
Study 1: Age Specific Dynamics of Sensory Neurons
The first experiment was designed to determine the normal pattern of development for
airway innervating sensory neurons in the nodose and jugular ganglia. Rat pups were instilled
with fluorescent microspheres on postnatal days (PD) 2 or 5 to retrogradely label neurons in
sensory ganglia innervating airway epithelium. On PD6, 10, 15, 21, or 28 ganglia were removed
and dissociated; neurons were isolated, purified, and counted using flow cytometry (Figure 5-1).
Study 2: Ozone or Filtered Air Exposure
The second experiment evaluated if a single acute O3 exposure in early postnatal life
might change the number of neurons containing the inflammatory neuropeptide SP that
innervate the airway, or the number of neurons innervating the airway. Animals were instilled
with fluorescent microspheres on PD5 to retrogradely label neurons in sensory ganglia
innervating airway epithelium. On the same day (PD5), rat pups were exposed to O 3, 2 ppm or
filtered air (FA) for 3 hr. Five, 10, 16 and 23 days post treatment (corresponding to postnatal
ages 10, 15, 21, and 28 respectively) ganglia were removed, dissociated and neurons were
isolated, purified, and counted using flow cytometry (Figure 5-2).
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Figure 5-1 (12)
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Figure 5-1. Experimental design for study 1: age specific dynamics of sensory neurons. To
examine the normal pattern of development of nodose and jugular sensory neurons innervating the
airways, tracheas of Fischer 344 rat pups were instilled with fluorescent microspheres on postnatal day
(PD) 2 (gray circle) or 5 (white circle). On PD6, animals beaded on PD2 were sacrificed (gray square),
while animals beaded on PD5 were euthanized on PD10, 15, or 28 (white square).
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Figure 5-2. Experimental design for study 2: ozone or filtered air exposure. Study 2: To determine if
neuron numbers were changing in response to an acute, early postnatal ozone (O3) exposure, 5-day-old
Fischer 344 rat pups were instilled with fluorescent microspheres to retrogradely label sensory neurons
innervating airway epithelium (circle). On the same day, pups were exposed to either O3 (2ppm) or filtered air
for 3hr (triangle). Rat pups were returned to their mother’s cages, where they remained until sacrifice 5, 10,
16, or 23 days after the exposure, which corresponded to PD10, 15, 21, and 28 respectively (square).
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5.3 Materials and Methods
5.3.1 Animals
Late gestation pregnant female Fischer 344 rats were purchased from Harlan
Laboratories and kept in filtered ventilated cages in an USDA approved, specific pathogen-free
and environmentally controlled animal facility. While in the vivarium, animals were provided with
HEPA-filtered air, autoclaved diet and tap water ad libitum and housed under controlled 12hr
light-dark cycle and temperature (22-24°C) conditions. After rat pups were born they were kept
in the same cage as the mother. Rat pups were analyzed on postnatal days (PD) 10, 15, 21 and
28. All procedures were done in accordance with IACUC regulations and approved IACUC
protocols.
5.3.2 Fluorescent Microsphere Instillation
Retrograde tracers were instilled into the tracheal lumen in order to identify sensory
neurons in the nodose and jugular ganglia that specifically innervate the airway epithelium.
Briefly, on PD2 or 5 depending on the study, rat pups were anesthetized via ice immersioninduced hypothermia (3-5 min; 4). The pups were placed inside a latex sleeve, to protect their
skin. When sufficiently anesthetized (unresponsive to foot pinch), trachea was exposed with a
midline incision in the skin on the ventral surface of the neck. Next, 2 µl (PD2) or 4 µl (PD5) of
Green Fluorescent RetroBeads™ (beads, LumaFluor Inc., Durham, NC) were instilled into the
tracheal lumen using a 10 µl Hamilton syringe. Incisions were closed using surgical glue. Rat
pups were revived using gentle warming and artificially ventilated if needed. When animals
regained consciousness and were breathing normally, pups were returned to their mother. As
the beads need a minimum of 4 days to travel from the epithelium to the cell body and It was
shown that the beads reach maximal uptake within 7 days of instillation (10), animals being
examined on PD6 received bead instillation on PD2, whereas all other age groups rat pups
received beads on PD5. Through preliminary studies it was determined that intratracheal bead
instillations did not result in airway inflammation as evidenced by a lack of neutrophil infiltration
in lung lavage fluid. Optimization of bead instillation volumes were also completed and the
selected volumes were found to result in the best survival rates at the specific ages.
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5.3.3 Ozone Exposure
Technical details of our ozone exposure apparatus have been published (27). On PD5,
following bead instillation, the rat pups were exposed for 3 hr to either O3 (2ppm) or filtered air
(FA) in a stainless steel-and-glass exposure chamber. Passing hospital-grade air through a
drying and high-efficiency particle filter and then through an ultraviolet light source produced O 3.
The O3 concentration in the chamber was measured by chemiluminescence with a calibrated O3
analyzer (model OA 350-2R, Forney, Carrollton, TX). In the FA exposed animals, procedures
were identical to those described above except O 3 was not delivered to the exposure chamber.
5.3.4 Nodose and Jugular Ganglia Neuron Isolation
At PD 10, 15, 21, or 28 pups were euthanized with an i.p. injection of sodium
pentobarbital (50 mg/ml), both vagus nerves were exposed and the left and right nodose and
jugular ganglia were removed. Neurons were isolated using a method previously described by
Kwong and Lee (16). Briefly, following removal, ganglia were desheathed, cut into smaller
pieces and placed in a 0.125% collagenase type IV in Dulbecco’s Modified Eagle Medium:
Nutrient Mixture F12 (DMEM/F12) media solution overnight at 37°C. To terminate collagenase
activity, the suspension was pelleted (150g, 5 min) and resuspended in a solution of 0.15%
trypsin EDTA in Hank’s Balanced Salt Solution (HBSS) (<1 min) repelleted (150g, 5 min) and
resuspended in modified DMEM/F12 solution. This final suspension, containing a mixture of
cells and cellular connective tissue fragments was layered on top of a solution of 15% bovine
serum albumin (BSA) in DMEM/F12. Subsequent centrifugation (500g, 8 min) through the BSA
solution resulted in the trapping of myelinated debris such that the remaining pellet contained
mostly neurons free of cellular and connective tissue fragments. The pelleted neurons were
collected and then prepared for flow cytometry.
5.3.5 Flow Cytometry Cell Preparation
Cell pellets containing isolated neurons were resuspended in 500 µl of DMEM/F12 media with
250 µl of BD Cytofix/Cytoperm Kit (BD Biosciences, San Jose, CA) for 20 min to fix and
permeablize them. Cells were incubated with a guinea pig primary antibody
(Chemicon/Millipore, Temecula, CA) against the pan-neuronal marker, protein gene product 9.5
(PGP-9.5) for 30 min at 4°C. After incubation, cells were washed twice to remove any unbound
primary antibody, followed by the addition of a R-Phycoerythrin (RPE) conjugated donkey antiguinea pig antibody (Jackson ImmunoResearch, West Grove, PA). Cells incubated with the

81

secondary antibody for 30 min at 4°C, and were then washed twice to remove any unbound
antibody. All cells were then incubated for 10 min at 4°C with 4’6-diamindino-2-phenylindole
(DAPI) (Sigma Aldrich, St. Louis, MO) in order to label nuclei of cells, washed to remove any
unbound DAPI, and resuspended in a final volume of 300 µl. Prior to analysis, samples were
passed through a 70µm cell strainer to remove any cellular debris that might remain. Cells were
analyzed on a BD FACSAria (BD Biosciences, San Jose, CA) located in the WVU Flow
Cytometry Core Facility using DIVA 6.1 software. For each sample, data were collected using a
constant flow rate for 60 sec. An event was considered an intact cell if it was DAPI +. Whole
cells were deemed neurons if they were both DAPI+PGP-9.5+. Neurons that innervate the
airways were identified as being FITC+ as an indicator of the retrograde transport of green
RetroBeads™.
In the second set of experiments, cells from animals in the O3/FA exposed groups were
also labeled for tachykinin, SP. During the primary antibody incubation a mouse monoclonal
primary antibody (R&D Systems, Minneapolis, MN) against SP was added at the same time as
the anti-PGP-9.5 antibody. In order to detect the SP, a Cy-5 conjugated goat anti-mouse
antibody (Jackson ImmunoResearch, West Grove, PA) was added along with the RPEconjugated secondary antibody. Other than these additions the same procedural steps were
taken as described above. This allowed for neurons to be further identified as SP + neurons
(non-airway SP-containing neurons, DAPI+PGP-9.5+SP+) or SP+ airway neurons (SP-containing
airway neurons, DAPI+PGP-9.5+FITC+SP+).
To calculate the number of neurons in each sample the following equation was used:
Number of Events
Volume Sampled

=

Neuron Number
Total Sample Volume

For each sample set analyzed, a tube containing a known volume of buffer was run
through the FASCAria for the same time and at the same flow rate used for sample analysis.
The volume sampled was determined by measuring the amount remaining in the tube.
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5.3.6 Data Analysis
Results of experiments are expressed as mean (+ SE). For an individual result to be
included in the study, it had to be within 2 standard deviations of the mean. Statistical analysis
was evaluated by using a one- or two-way (age and O3/Air) ANOVA. When an effect was
considered significant, a pair-wise comparison was made with a post hoc analysis. A value of p
less than 0.05 was considered significant for each endpoint and n represents the number of
animals studied per experimental group. An n=6 was used for each age group unless otherwise
noted.

5.4 Results
5.4.1 Identification and Confirmation of Neurons
The number of neurons contained in the nodose and jugular ganglia was determined
using flow cytometry. This method allows for unbiased, absolute counting, as well as the ability
to identify multiple populations of neurons in a single run. Cells were first identified as being
DAPI+, which indicated the presence of an intact nucleus (Figure 5-3A: blue box). From the
DAPI+ population, the neuron specific marker, PGP-9.5, was used to determine which cells were
neurons as shown in Figure 5-3B: lower right quadrant (total neurons; DAPI+PGP+). Neurons
projecting to the airway epithelium were neurons that contained Retrobeads™ (airway neurons;
DAPI+PGP+FITC+) as seen in Figure 5-3B: upper right quadrant. Samples prepared for flow
cytometry were also observed by confocal microscopy to confirm the structural and labeling
attributes of neurons. Figure 5-4 shows an example of a non-airway neuron. It is labeled for
PGP-9.5, indicating a neuron, DAPI showing that it is a whole cell with a nucleus, and had no
microspheres indicating it was not a neuron projecting to the airway epithelium. The neuron in
Figure 5-5 was labeled for both PGP-9.5 and DAPI, and was also labeled with green
microspheres transported from the airway, indicating that this neuron projected to the airway
epithelium.
In order to determine the numbers of SP containing neurons in O3/FA exposed animals,
total and airway neurons were first identified. From the DAPI+ population, cells were classified
as neurons (PGP-9.5+) and were then categorized as either being non-airway SP-containing
neurons (SP+ neurons, DAPI+PGP+SP+), or SP-containing airway neurons (SP+ airway neurons,
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DAPI+PGP+FITC+SP+) as seen in Figure 5-3C (lower right quadrant and upper right quadrant,
respectively). Figure 5-6 is a representative image of a SP-containing airway neuron,
demonstrating labeling with DAPI, PGP-9.5, green beads (FITC) and SP.
5.4.2 Age Specific Dynamics of Sensory Neurons
Nodose and jugular ganglia sensory neurons were isolated from rat pups during early
postnatal life (PD6, 10, 15, 21, and 28) in order to determine the pattern of normal sensory
neuron development of all neurons in the nodose and jugular ganglia and of a subpopulation of
neurons innervating the airway epithelium (refer to Figure 5-1).
5.4.2a Total Nodose and Jugular Ganglia Neurons (DAPI+PGP-9.5+)
Using FACS, it was determined that the number of neurons at PD6 was 924(+470;
Figure 5-7A). There was a significant increase in total neurons between PD6 and PD10
(8197+1170), which remained elevated at all subsequent ages examined (PD15=9677+2596;
PD21=6185 +547; PD28=6765 +1745). Neuron numbers on PD10 through PD28 were not
significantly different from each other. To confirm the quantitative and significant increase in
neuron number between PD6 and PD10, ganglia from both ages were removed, weighed,
processed for immunohistochemistry and visualized using confocal microscopy. Ganglia
removed from PD10 animals (n=3) weighed significantly more than ganglia from PD6 (n=3) rats
(Figure 5-8).
5.4.2b Airway Neurons (DAPI+PGP-9.5+FITC+)
The number of airway neurons at PD6 was 83 (+35). Neuron numbers rose significantly
to 439 (+51) on PD 10. Airway neuron numbers remained significantly elevated relative to PD6
on PD15 (253 +73) and PD28 (453 +105). PD21 (169 +26) was not significantly different from
any other age (Figure 5-7B). Altogether, these results indicate that a substantial increase in
total nodose and jugular neurons and in airway neurons occurs during the early periods
between PD6 and 10, and that neuron numbers stabilize from PD10 through PD28.
5.4.3 Ozone or Filtered Air Exposure
On PD5, rat pups were instilled with RetroBeads™, exposed to O 3 or FA, then nodose
and jugular ganglia sensory neurons were isolated and counted 5, 10, 16, and 23 days after
exposure to elucidate if a single acute O 3 exposure might affect sensory neuron development
(see Figure 5-2).
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5.4.3a Total Neurons (DAPI+PGP-9.5+)
Total nodose and jugular ganglia neuron numbers in PD21 rat pups exposed to O 3 (2845
+1132; n=9) were significantly less than the number of neurons seen in PD21 FA exposed rat
pups (10542 +3150; n=7). Although no other significant differences were seen between groups,
total nodose and jugular neuron numbers in O3 exposed animals were less than the numbers
noted in FA exposed animals at PD15, 21, and 28 (Figure 5-9A). Ganglia removed from PD 21
animals exposed to both FA (n=3) and O3 (n=3) revealed that ganglia from O3 exposed animals
weighed less than ganglia from FA controls (Figure 5-10). Thus, O3 exposure resulted in a
marked reduction in total neuron number in the entire nodose and jugular ganglia compared to
FA controls.
5.4.3.b SP+ neurons (DAPI+PGP+SP+)
The numbers of SP+ neurons in the total nodose and jugular ganglia of the O3 group
were less than the numbers of SP+ neurons in the FA group at every time point except PD28
(Figure 5-9B). Although no significant differences were observed at any postnatal age, the
difference at PD21 rose numerically, (FA- exposed, 1938 + 793, n=7 and O3- exposed, 525 +
129, n=8) suggesting a possible reduction in total SP neuron numbers after O 3 exposure.
5.4.3c Airway Neurons (DAPI+PGP-9.5+FITC+)
Although no significant differences were found in airway neuron numbers between the
O3 and FA groups at any time point, the numbers of airway neurons in O3 exposed animals
were quantitatively lower than airway neuron numbers seen in FA controls at PD10, 15, and 21,
(Figure 5-11A). While airway neuron numbers in both exposure groups were maximally
increased at PD21, as was the case with the numbers of total nodose and jugular neurons, a
single early postnatal O3 exposure did not produce a similarly large decrease in airway neuron
number.
5.4.3d SP+ airway neurons (DAPI+PGP+FITC+SP+)
The numbers of SP+ airway neurons in O3 exposed groups were not markedly different
from the numbers found in FA groups (Figure 5-11B). However, at PD28, 23 days post
exposure, the numbers of SP+ airway neurons in the O3 group (41 +9; n=14) were quantitatively
greater than in the FA exposed group (18 +6). Data indicate that an acute, early postnatal O3
exposure might play a role in sustaining a specific subpopulation of airway neurons known to
play an important role in inflammatory responses in the airways.
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Figure 5-3 (14)

A
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DAPI-

B

C
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DAPI+PGP-9.5+

DAPI+PGP-9.5+SP+

Figure 5-3. Identification of Nodose and Jugular Ganglia Neuron Populations using
flow cytometry. Representative scatter plots from flow cytometry experiments. Neurons
contained in the nodose and jugular ganglia were identified using flow cytometry as being (A)
whole cells; DAPI+, (B) neurons; DAPI+ PGP-9.5+, airway neurons; DAPI+ PGP-9.5+ FITC+,
(C) Substance P neurons; DAPI+ PGP-9.5+ SP+, or Substance P airway neurons; DAPI+
PGP-9.5+ FITC+ SP+.
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Figure 5-4 (15)
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PGP-9.5 +

MERGED

Figure 5-4. Representative confocal microscopy image of a nodose and jugular neuron
following flow cytometry quantification. Image was taken on a Zeiss LSM 510 confocal
microscope using a 63x/1.4 oil immersion objective. A z-stack (5 sections at 1µm intervals)
was taken of each neuron, flattened and a median filter applied using Zeiss AIM software.
Contrast was adjusted to enhance detail.
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Figure 5-5 (16)
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Figure 5-5. Representative confocal microscopy image of a nodose and jugular airway
neuron following flow cytometry quantification. Image was taken on a Zeiss LSM 510
confocal microscope using a 63x/1.4 oil immersion objective. A z-stack (5 sections at 1µm
intervals) was taken of each neuron, flattened and a median filter applied using Zeiss AIM
software. Contrast was adjusted to enhance detail.
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Figure 5-6 (17)
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Figure 5-6. Representative confocal microscopy image of a substance P (SP) airway neuron
following flow cytometry quantification. Image was taken on a Zeiss LSM 510 confocal microscope
using a 63x/1.4 oil immersion objective. A z-stack (5 sections at 1µm intervals) was taken of each
neuron, flattened and a median filter applied using Zeiss AIM software. Contrast was adjusted to
enhance detail.
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Figure 5-7. Age specific dynamics of sensory nodose and jugular ganglia neurons in postnatal day (PD)
6,10,15, 21, and 28 rats. Total and airway neurons were quantified in this study. All quantifications were done on
the FASCSAria Flow Cytometer. Neuron numbers represent the average of all animals sampled for a particular
age group. (A) Quantification of total nodose and jugular ganglia neurons (DAPI+ PGP-9.5+) found that PD6 rat
pups significantly less total neurons than PD 10, PD15, PD21, and PD28 animals (* p<0.05). (B) Neurons that
innervated the airway were labeled using a green fluorescent retrograde tracer, identified as DAPI+PGP-9.5+FITC
+ and then quantified. PD10, PD15 and PD28 animals significantly more neurons than PD6 (* p<0.05) rats. The
number of airway neurons in PD21 animals was not significantly different from any other day examined. n=6 for
each age group.
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Figure 5-8. Differences in nodose and jugular ganglia gross wet weight postnatal day (PD) 6 and
PD10 rats. Ganglia were removed from PD6 (n=3) and PD10 (n=3) animals, weighed and
immunohistochemically processed for PGP-9.5 and counterstained with DAPI. Ganglia from PD10 rats
weighed significantly more than ganglia from PD6 pups (* = p<0.05).
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Figure 5-9 (20)
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Figure 5-9. Effect of acute postnatal ozone exposure on total nodose and jugular neuron number and total
substance P containing neuron number in rats. Rat pups were exposed to ozone (O3; 2ppm) or filtered air (FA)
for 3hr on postnatal day (PD) 5, and then euthanized on PD10, 15, 21, or 28. Total neurons and total substance P
(SP) neurons were quantified. All quantifications were done on the FASCSAria Flow Cytometer. Neuron numbers
represent the mean of all animals sampled for a particular age group. (A) On PD21, the number of total neurons in
O3 exposed animals was significantly less than the neuron number in the FA group (* p<0.05). (B) There were no
significant differences between exposure groups in the number of SP neurons. The n value for each age group is
listed in parentheses.
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Figure 5-10 (21)
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Figure 5-10. Differences in nodose and jugular ganglia gross wet weight in postnatal day (PD) 21 rats
following ozone or filtered air exposure on PD5. Rat pups were exposed to ozone (O3; 2ppm; n=3) or
filtered air (FA; n=3) for 3hr on postnatal day (PD) 5, and then euthanized on PD21. Nodose and jugular
ganglia were removed, weighed, and immunohistochemically processed for PGP-9.5 and counterstained with
DAPI. Ganglia from PD21 animals exposed to FA weighed more than ganglia removed from animals exposed
to O3.
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Figure 5-11 (22)
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Figure 5-11. Effect of acute postnatal ozone exposure on airway neuron number and substance P
containing-airway neuron number in rats. On postnatal day (PD) 5 rat pups were intra-tracheally instilled with
fluorescent microspheres, to identify nodose and jugular airway neurons, exposed to ozone (O3; 2ppm) or filtered
air (FA) for 3hr, and then euthanized on PD10, 15, 21, or 28. The number of airway neurons and the number of
substance P (SP) airway neurons quantified. All quantifications were done on the FASCSAria Flow Cytometer.
Neuron numbers represent the mean of all animals sampled per age group. (A) No significant difference in airway
neuron number was found between O3 and FA exposed groups. (B) Quantification of SP airway neurons found no
significant differences between exposure groups. The n value for each age group is listed in parentheses.
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5.5 Discussion
The results of this study show that the numbers of labeled airway sensory neurons and
the total number of neurons of the nodose and jugular ganglia during early postnatal
development, increase between PD6 and 10 and then generally stabilize. Animals exposed to
O3 early in postnatal life show a quantitative reduction in total nodose and jugular ganglia
neurons on PD 15, 21, and 28, compared to FA controls. Airway neuron numbers in O 3-exposed
animals were also quantitatively decreased compared to FA control animals. The numbers of
total SP-containing neurons were no different from numbers found in FA controls. The number
of SP-containing airway neurons in O3 exposed rats were increased on PD28 (23 days post
exposure), while in FA controls the numbers of SP + airway neurons at the same time point were
decreased.
5.5.1 Use of Flow Cytometry for Neuron Counts
Traditionally neuron counts are conducted using immunohistochemistry in conjunction
with confocal microscopy, followed by analysis using stereology software. For this study
however, flow cytometry was chosen as the preferred counting method for several reasons.
Firstly, flow cytometry allowed us to count whole, three-dimensional (3-D) neurons, as opposed
to the two-dimensional (2-D) counting that is accomplished with confocal microscopy. The
advantage of counting neurons in 3-D, is that the chances of counting the same neuron twice
are virtually eliminated. Secondly, by counting neurons using flow cytometry, the sample
throughput is increased exponentially. The process of preparing neurons for counting
essentially requires the same amount of time as it would to prepare sections for counting,
however 40 samples or more can be analyzed in a single day using flow cytometry as opposed
to weeks it might take to count neurons from the same number of animals using tissue sections.
A third advantage of flow cytometry is that human bias is virtually removed from counting.
Instead of a person deciding if a neuron is positive, as is the case in counting by eye, neurons
pass a highly sensitive detector that determines if fluorescence is higher than unstained and
positive control samples. One final reason flow cytometry was employed in this study, is
because it allowed for multiple neuronal markers to be analyzed simultaneously in a single
sample. However, possible limitations of this technique that could lead to potential variation in
results are that 100% of airway neurons will not be labeled with Retrobeads ™ nor will 100% of
neurons be recovered following ganglia dissociation. Additional limitations include variation in
dissecting techniques and in antibody labeling due to disparities in manufacturing. Nevertheless
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the advantages far outweighed the positives of using traditional sectioning to determine neuron
number in the nodose and jugular ganglia.
5.5.2 Age Specific Changes in Neuron Number
5.5.2a Total Nodose and Jugular Ganglia Neurons
The numbers of total neurons determined in this study differ from numbers found in
studies by Bakal and Wright (1) and Cooper (3). Bakal and Wright (1) found that total neuron
number in the nodose ganglion decreased between postnatal days 1 and 14, while Cooper (3)
noted that nodose neuron numbers remained constant from birth. The current study showed
that neuron numbers rise between PD6 and PD10, and then stabilize (Figure 5-7A). Both of the
previous studies used microscopy techniques to estimate total neuron number. In the current
study, neurons from the nodose and jugular ganglia were isolated and counted individually,
using flow cytometry, allowing for more exact counting and decreased stereological bias.
Because neuron isolation was used in this study, no distinction was made between nodose and
jugular ganglia, which is the most likely explanation for the overall larger neuronal number in our
study.
5.5.2b Airway Neuron Number
The utilization of retrograde tracing to identify neurons innervating the airway epithelium
in this study allowed for the examination of a specific neuronal population that is known to
mediate defensive and inflammatory responses in the lung, including the release of SP and
neuronal reflexes (20, 21). This is the first time the numbers of this subpopulation of neurons
was examined in vivo in the context of postnatal development.
The significant increase in airway neuron number between PD6 and PD10 (Figure 5-7B)
might be interpreted in several different ways. The first is that neuron proliferation is occurring
and that new neurons send new axons to the airway epithelium where they are subsequently
labeled with Green Retrobeads. However, this seems to be an unlikely explanation because the
growth and development of a new, airway-innervating neuron that would be retrogradely labeled
with beads would take longer than the maximum 4 days. Yet, given the quantitative increase in
airway neuron numbers, this possibility should not be discounted and requires further study. A
second, and more likely possibility is that the rise in neuron number may be attributed to
neurons, present in the nodose and jugular ganglia at PD6, whose axons were destined to
innervate the airway epithelium but had not yet reached that target until PD10. If the axons
were not yet in the epithelium to take up the beads the cell body would not be labeled when
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analyzed at PD6 but would be labeled when neuron counts were performed at PD10.
5.5.3 Changes in Neuron Number Following Early Postnatal Acute O3 Exposure
5.5.3a Total Neuron Number
This study determined that the number of total neurons in the nodose and jugular
ganglia of animals exposed to O 3 on PD5, was markedly lower than the neuron number found in
FA controls at all ages and significantly lower at PD21 (Figure 5-9A). Despite this sizeable
reduction in neuron number, no marked differences were noted between FA and O 3 exposed
rats in either body weight or behavior (feeding, grooming, activity, etc). One possible
explanation for this significant decrease might be that neurons in the nodose and jugular ganglia
also innervate other organs including the heart and stomach. The large fall in neuron number
might be attributed to a reduction in neurons innervating those organs. While the studies
conducted here focused on the effects of an inhaled O3 exposure, as animals are placed in an
exposure chamber, systemic O3 exposure is unavoidable. O3 entering the GI tract may directly
interact with nodose and jugular afferent fibers, which might adversely affect neuronal survival.
In addition O3 penetrating the body through skin enters the bloodstream where the gas
immediately reacts with biologically active molecules resulting in the formation of free radicals.
Circulating free radicals can damage cells, as well as alter protein synthesis and DNA
replication (24, 25). Any of these adverse conditions might result in cell death, which may be a
possible explanation for the significant fall in total neuron number found in this study.
5.5.3b SP+ Neuron Number
The number of SP+ nodose and jugular neurons in O3 exposed animals was quantitatively lower
than the number seen in FA exposed controls at PD 10, 15, and 21 (Figure 5-9B). The lack of
change in total number of SP+ neurons between FA controls and O3 exposed animals was
expected, as the SP+ neurons are a small subpopulation of the total neurons.
5.5.3c Airway Neuron Number
The numbers of nodose and jugular airway neurons in O3 exposed rat pups were
numerically lower (Figure 5-11A). Although this result was unexpected it is particularly
interesting when taking into account the quantitative decrease in total nodose and jugular
neuron number that was seen following O 3 exposure. Our finding that early postnatal O3
exposure lowered total neuron number, which had no marked effect on airway neuron number,
may indicate that airway neurons possess protective mechanisms allowing them to survive
following O3, while non-airway neurons are more adversely affected.
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5.5.3d SP+ Airway Neuron Number
No significant difference in SP+ airway neuron number was found between FA controls
and O3 exposed rat pups (Figure 5-11B), however the quantitative increase on PD28 in SP+
airway neurons 23 days post O3 exposure, is noteworthy. It may lend insight into why Hunter et
al. (9) found a rise in the % of SP+ airway neurons in rat pups administered Nerve Growth
Factor (NGF) on PD6 and later exposed to O3 on PD28. O3 exposure increased both NGF
measured in bronchoalveolar lavage fluid and relative levels of NGF mRNA in tracheal epithelial
cells (9). In sensory neurons, neuropeptide gene and peptide expression is upregulated by
NGF (21). The quantitative changes in SP+ airway neurons following acute early postnatal O3
might be mediated by alterations in the amount of NGF present in the airway at developmentally
critical periods. While experiments determining how instillation of NGF into the airways affects
the numbers of both airway neurons and SP+ airway neurons, the results of this study may play
a role in helping to elucidate the intermediary steps in the mechanism of O 3-induced changes in
sensory airway innervation that are occurring during postnatal airway development.
5.5.4 Conclusions
Overall this study shows that the development of sensory neurons in nodose and jugular
ganglia is a dynamic process that is not only occurring in an age-related manner, but might also
be altered by acute O3 exposure in early postnatal life.
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CHAPTER 6:
General Discussion and Conclusions
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The normal postnatal development of airway sensory innervation is discussed, including
age specific dynamics of nodose and jugular neuron number, changes in the amount of afferent
nerve innervation, differing levels of NGF in the airway throughout postnatal development and
the interactions between these different components. The effects of an early life irritant
exposure on neurons in the nodose and jugular ganglia are subsequently discussed. Finally,
general conclusions together with the implications of these results complete this chapter.

6.1 Discussion of Normal Postnatal Airway Sensory Neural
Development
6.1.1 Summary of Results Respective of Age
The major findings of the studies contained within this dissertation reveal that early
postnatal life is a time during which airway sensory neural development is undergoing dynamic
changes. The amount of NGF measured in BALF at different postnatal ages was not static
(Chapter 3; Figure 3-2). Innervation levels of the airway epithelium (nerve fiber density) also
fluctuated during development (Chapter 3; Figure 3-1B). The number of total neurons in the
nodose and jugular ganglia and the numbers of neurons specifically innervating the airways
(airway neurons) also varied with age (Chapter 5; Figure 5-7). The following table (Table 6-1)
summarizes differences in each parameter at the postnatal ages examined.
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Table 6-1
Postnatal
Age

Parameter

Difference with respect to ages

NGF in BALF*
Epithelium NFD*
Airway Neurons^
Total Neurons^
NGF in BALF*
Epithelium NFD*
Airway Neurons^
Total Neurons^
NGF in BALF*
Epithelium NFD*
Airway Neurons^
Total Neurons^
NGF in BALF*
Epithelium NFD*
Airway Neurons^
Total Neurons^

Lowest concentration
Significantly greater than PD28
PD6
Fewest number
Fewest number
Significantly increased over any other age
Significantly increased over PD21 & PD28
PD10
Significantly increased over PD6 & PD21
Significantly more than PD6
Quantitatively more than PD6, PD21 & PD28
Quantitatively more than PD21 & PD28
PD15
Quantitatively more than PD6 & PD21
Greatest number, Significantly more than PD6
Low concentration
Low concentration
PD21
Quantitatively fewer than all days but PD6
Significantly more than PD6; Quantitatively fewer than PD10,
PD15, & PD21
NGF in BALF*
Low concentration
Epithelium NFD* Low concentration
PD28
Airway Neurons^ Significantly more than PD6 & PD21
Total Neurons^ Significantly more than PD6; Quantitatively fewer than PD10
& PD15, Quantitatively more than PD21
* Results found in Chapter 3; ^ Results found in Chapter 5

6.1.2 Airway Neuron Number
As previously described the significant increase in airway neuron number between PD6
and PD10 (Chapter 5, Figure 5-7B) could be interpreted in several different ways. The first is
that neuron proliferation is occurring and that new neurons send new axons to the airway
epithelium where they are subsequently labeled with Green Retrobeads. A second possibility is
that the increase in neuron number could be attributed to neurons, present in the nodose and
jugular ganglia at PD6, whose axons were destined to innervate the airway but had not yet
reached that target until PD10. If the axons were not yet in the airway to take up the beads the
soma would not be labeled when analyzed at PD6 but would be labeled when neuron counts
were preformed at PD10. A third possibility is that this increase is a combination of the two
aforementioned theories. As the beads need a minimum of four days to travel from the airway to
the cell body (9), animals being examined on PD6 received bead instillation on PD2, whereas all
other age groups rat pups received beads on PD5. Neurons from rats being analyzed for the
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PD10 group would have had only one additional day for bead uptake, which we do not believe
would be sufficient time to account for the large increase in neuron number that was observed.
It has been shown that the RetroBeads reach maximal uptake within seven days of instillation
(9), therefore increasing the number of days that beads were available for uptake should not
play a role in the differences in neuron number seen at later time points.
The increase in airway neurons between PD21 and PD28 is harder to explain. It is
possible that changes in the availability of trophic factors between PD21 and PD28 cause this
increase in airway neuron number. A study conducted by Lommatzsch et al. in 2005 found that
in the first few weeks after birth, specifically between PD1 and PD21, the levels of both NGF
and BDNF decreased in the lungs, although the concentration of BDNF was always higher than
the concentration of NGF. The same study found that BDNF concentrations increased from
PD21 onward, while NGF levels remained low (19). In addition, adult neurons from the nodose
placode are responsive to BDNF for growth and support (15), and isolated airway smooth
muscles cells produce BDNF (14). Thus, it may be that trophic support by NGF in epithelium is
receding while BDNF support from airway smooth muscle is increasing. This could explain the
recovery of airway neuron numbers in the face of decreasing NGF at PD21 and 28.
Another possibility for the rebound of airway neuron numbers between PD21 and 28 is
that Trk receptor expression changes. If airway neurons express more TrkB or less TrkA, in
theory there would have an increased probability that these neurons would preferentially
respond to BDNF rather than NGF. A decrease in the amount of NGF could be the signal that
instigates receptor switching, or perhaps increasing levels of BDNF is a catalyst for initiating
changes in receptor expression.
An additional factor that may have affected the developmental dynamics of airway
neurons is that the animals were weaned during the time period between PD21 and 28, which
could have affected neuronal development. There are several possible stressors that can occur
as a result of weaning and stress has been shown to directly affect airway sensory neurons in
adult mice (13).

6.1.3 Total Neuron Number
Older animals had significantly more total nodose and jugular ganglion neurons than
PD6 rat pups (Chapter 5; Figure 5-7A). Though the highest number of neurons was recorded in
PD15 animals, the results of this study revealed that total neuron number in these ganglia
105

begins to stabilize in the vicinity of PD10. The increase in neuron number was expected since
ganglia size and weight (Chapter 5; Figure 5-8) increased as animals aged, and the increase in
size is not thought to be strictly related to an increase in connective tissue within the ganglia.
Though studies conducted using EdU (Chapter 4; Figure 4-5) did not uncover proliferation
occurring in the ganglia, these studies were conducted to determine if mitosis was responsible
for large increases in neuron numbers between PD21 – 28 observed in preliminary studies.
Experiments to determine if proliferation was occurring at early postnatal ages were not
repeated, and, therefore, the possibility of neuronal proliferation still exists. Also because
neurons contained in the nodose and jugular ganglia innervate several different target organs, it
is difficult to draw conclusions on the significance of the finding that total neuron numbers
increase significantly between PD6 and 10.
When comparing findings from different parameters on the basis of postnatal age, a
pattern appears to emerge (Table 6-1). Epithelial NFD, NGF in BALF, and airway neuron
number, are highest on PD10, indicating that this age may be very important in terms of airway
sensory neural development. Because all of these airway specific parameters were significantly
increased at PD10, we attempted to discern if there was any correlation between the measured
factors.

6.1.4 NGF Levels in BALF vs. Epithelium NFD
As discussed in Chapter 3, no correlation was found between NGF levels in BALF and
epithelium NFD (r2= 0.5531). However, the lack of correlation is not indicative that NGF levels in
the airways are entirely unimportant in determining the amount of epithelial innervation (Chapter
3, Figure 3-3). Transgenic mice that over-express NGF specifically in Clara cells have
hyperinnervated airways (7). Pioneering studies examining the effects of NGF on neurons
demonstrated that neurite outgrowth was significantly increased in the presence of NGF(3).
NGF is produced and released from epithelial cells as well as resident immune cells present in
the airways (1, 4, 16, 21, 22). A study that determined relative NGF mRNA levels in isolated rat
tracheal epithelial cells (RTEs) found that NGF mRNA expression was also greatest at PD10.
Although an increase in mRNA expression does not necessarily equate to increased protein
production and release this result may indicate that RTEs are a significant source of NGF in the
airways (8). However, if the epithelium and immune cells are not stimulated to release NGF into
the lumen, it would not be measured in the lavage fluid, and as such, NGF levels measured in
lavage fluid do not represent the total amount of NGF in the airway.
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6.1.5 NGF Levels in BALF vs. Nodose and Jugular Ganglia Airway Neuron
Number
Correlation statistics showed that NGF levels in BALF correlated with the number of
airway neurons in nodose and jugular ganglia up until PD21 (r2= 0.9528, p=0.0472). When the
PD28 age group was included no correlation was found (r2=0.3444). A possibility for the lack of
correlation in later postnatal life is that receptor expression on the afferent neurons projecting to
the airways may also vary. Though not measured as part of this dissertation, changes in Trk
receptor expression would affect the responsiveness of sensory afferents to trophic support in
the epithelium. If TrkA receptor expression decreased, neurons would have an attenuated
response to NGF and, in turn, neuronal number would be unaffected by changes in NGF.
Another possible reason that airway neuron numbers in PD28 animals do not correlate
with NGF levels at the same age is that NGF concentrations in the airway may not be uniform.
The studies conducted here used bronchoalveolar lavage to determine the levels of NGF in the
airways at different postnatal ages. Bronchoalveolar lavage allows for the measurement of NGF
contained in the airway lumen; however, the location of relative NGF concentrations in the
airway cannot be determined. Studies conducted in guinea pigs examining the somatic origin of
sensory airway innervation patterns have revealed that the sensory afferents in the trachea
primarily originate from the jugular ganglia, while the majority of nodose ganglion neurons
innervating the airways terminate within the intrapulmonary compartment (17). The differing
airway locations of the nerve terminals of sensory afferents originating in the nodose and jugular
ganglia present the possibility that a variance in the availability of neurotrophins exists. So while
airway neurons may still be responsive to NGF later in life, afferent nerve location could be a
large determinant of their access to NGF. Likewise, NGF measured in BALF is not a
measurement of total NGF in the airways, as the amount of NGF contained within cells (i.e. not
in the lumen) is not accounted for.

6.1.6 Epithelium NFD vs. Nodose and Jugular Ganglia Airway Neuron Number
Though both airway neuron number and epithelium NFD are increased at PD10 and
decrease similarly through PD21, no correlation between the two parameters was found
(r2=0.0003). The lack of correlation is most likely due to axonal arborization within airway
epithelium. A single airway neuron might have an epithelium innervating axon with multiple
arborizations and therefore changes in epithelium NFD would not represent changes in neuron
number. Likewise, if a single airway neuron died epithelium NFD might not decrease in a
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similar fashion as axonal arborization from a surviving neuron might occur in an effort to
maintain proper target innervation.

6.1.7 Airway Neuron Number vs. Epithelium NFD vs. NGF levels
A more compelling indicator of a possible relationship between the airway specific
parameters measured during normal development is revealed when examining all three on the
same graph. In Figure 6-1, the pattern that emerged in Figure 3-3 between epithelium NFD and
NGF levels becomes more evident with the addition of airway neuron numbers. All parameters
show rapid increases between PD6 and PD10; NFD, NGF levels and airway neuron numbers
were all significantly increased at PD10; all measurements decreased after PD15; and with the
exception of airway neuron numbers, remained low through PD28.
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Figure 6-1
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Figure 6-1. Comparison of airway neuron number, nerve growth factor levels and epithelium
nerve ﬁber density during normal development. When graphed together a pattern emerges
that appears to indicate a relationship between these three airway speciﬁc parameters.
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6.2 Discussion of Postnatal Airway Sensory Neural Development
Following Acute Early Ozone Exposure
6.2.1 Summary of Results Respective of Age
The major findings of the studies designed to examine the effects of an acute O3
exposure on nodose and jugular neuron number show that a single O 3 exposure on PD5 can
affect sensory neuron development in the nodose and jugular ganglia. In the four neuronal
populations examined, animals exposed to O3 in early postnatal life had fewer neurons than FA
exposed counterparts. The number of total nodose and jugular ganglia neurons in O 3 exposed
rats was substantially lower at all ages examined and significantly lower on PD21 (Chapter 5;
Figure 5-9A). The number of SP+ neurons in rats exposed to O3 was lower than neuron
numbers found in FA exposed animals at all postnatal days (Chapter 5; Figure 5-9B). Airway
neuron numbers were slightly lower at all ages except PD28 in O 3-exposed animals (Chapter 5;
Figure 5-11A). O3-exposed rat pups had slightly lower numbers of SP+ airway neurons on PD10
and 15, slightly greater on PD21, and nearly significantly greater on PD28 (Chapter 5; Figure 511B). The following table (Table 6-2) summarizes how each of the four neuronal populations
examined change after a single O3-exposure on PD5 when compared with neuronal numbers
quantified from rats exposed to FA on PD5.
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Table 6-2
Postnatal
Age
PD10

PD15

PD21

PD28

Neuronal
Population
Total Neurons
SP+ Neurons
Airway Neurons
SP+ Airway Neurons
Total Neurons
SP+ Neurons
Airway Neurons
SP+ Airway Neurons
Total Neurons
SP+ Neurons
Airway Neurons
SP+ Airway Neurons
Total Neurons
SP+ Neurons
Airway Neurons
SP+ Airway Neurons

Difference in neuron number in relation to FA
exposed rats
Quantitatively fewer, no significant difference
Quantitatively fewer, no significant difference
No significant difference
No significant difference
Quantitatively fewer, no significant difference
Quantitatively fewer, no significant difference
Slightly fewer, no significant difference
No significant difference
Significantly fewer
Substantially fewer, no significant difference
Quantitatively fewer, no significant difference
Quantitatively more, no significant difference
Quantitatively lower, no significant difference
Quantitatively lower, no significant difference
Quantitatively more, no significant difference
Quantitatively more, near significant difference

6.2.2 Total Neuron Number
The large decrease in total neuron number following an acute early life O 3 exposure was
not anticipated (Chapter 5; Figure 5-9A). As previously discussed, the substantially lower
numbers of nodose and jugular neurons could be due to mixed target tissue innervation. By
administering O3 via inhalation, other organs, such as the heart and GI tract, which also receive
sensory innervation from nodose and jugular ganglion neurons, were possibly exposed to an
undetermined concentration of O 3, through the blood stream or through swallowing. Based on
the experiments performed here, it is unclear whether the O3 exposure resulted in systemic
effects. Though the considerable decrease in the number of nodose and jugular neurons
appears to be indicative of an effect of O 3 on neuronal survival.

6.2.3 Substance P Neuron Number
Previous work examining changes in SP neuron number in nodose and jugular ganglia
following an exogenous stimulus (NGF, ozone, allergen) differ from work presented here in that
previous studies investigated differences in SP immunoreactivity (SP-IR) only 24 hrs post
agonist treatment (2, 8, 11). The results presented in those studies revealed that the number of
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SP-IR neurons were increased 24 hrs after agonist administration. It might then be expected
that the acute O3 exposure on PD5 in this study would elicit a similar result; however that was
not the case. No significant differences in SP neuron number following O 3 were seen at any
age, though neuron numbers in O3 exposed animals were lower than neuron numbers in FA
exposed animals on PDs10, 15 and 21 (Chapter 5; Figure 5-9B). As the SP neurons are a
subpopulation of the total neurons, the large changes observed in total neuron numbers
between FA and O3 groups result in no difference in the number of SP neurons, despite the
seemingly large differences between FA and O3 exposed groups.

6.2.4 Airway Neuron Number
Though O3 exposed rats had slightly fewer airways neurons than FA-exposed animals,
no significant difference in airway neuron number was noted (Chapter 5; Figure 5-11A). This
result was unanticipated given the sizeable differences in total neuron numbers, as it would be
expected that a large reduction in total neuron number would affect at least a small proportion of
airway neurons. It might then be reasoned that in O3-exposed rats observing no difference in
airway neuron number, while at the same time noting large decreases in total neurons, could be
indicative of a protective effect an acute O3-exposure in early postnatal life has on the survival
of airway neurons. The phenomenon of early postnatal O 3-exposure positively affecting
neuronal number has, to my knowledge, not been previously described. The exposure
paradigm and outcome measurements employed in these studies made it possible to observe
the effects of an acute O3 exposure on postnatal airway neuron development.

6.2.5 SP+ Airway Neuron Number
The number of SP positive airway neurons in O3 exposed animals was expected to be
greater than the SP+ airway neuron number determined in FA exposed animals; however, no
differences were found (Chapter 5; Figure 5-11B). Studies conducted in rat show an effect of
early O3 exposure on airway reactivity, SP content in sensory afferent nerve fibers, and levels of
NGF in the airway lumen. Hunter et al. (12) found a significant increase in SP NFD in the
airways of rats initially exposed to O 3 on PD4 and then re-exposed to O3 on PD28. This
increase was not seen in groups that received initial O3 exposures later in life (PD21), or in
groups receiving FA rather than O3 on PD28 (12). This work revealed that airway sensory neural
development is potentially more susceptible to the adverse effects of O3 exposures occurring
during early postnatal life. The same group found that O 3 exposure increased NGF levels
measured in the airways, 24 hrs post exposure (8). NGF is known to increase tachykinin gene
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expression in sensory neurons (18), as well as increase the number of SP-IR nodose and
jugular neurons (10).
Further examination of the effects of exogenous stimuli on early postnatal airway
sensory neural development demonstrated that rats receiving intratracheal NGF administration
on PD6, and O3 exposure on PD28 had an increased percentage of SP-IR airway neurons (8).
Airway neuron SP-IR was unchanged in groups that received NGF instillations later in postnatal
life, vehicle rather than NGF, or FA instead of O3 exposure. Therefore, with two potentially
linked mechanisms for increasing SP-IR in nodose and jugular neurons, an increase in SP
positive airway neurons following acute ozone in early postnatal life was probable. Though
experiments conducted for this dissertation did not show a difference in SP positive airway
neuron number, alterations in when data was collected following O 3 exposure, and differences
in the exposure paradigm between the studies, most likely account for this.
Early postnatal increases of inflammatory mediators in the airway may result in altering
the regulation of tachykinin gene expression, inasmuch that the amount of gene expression in
older animals may be lower when no airway insult occurs in early life. Studies conducted in
humans found that adults have lower levels of SP innervation than infants and children (6). This
appears to indicate a decrease in preprotachykinin-1 (PPT-1) gene expression, although a
decrease in translation of SP protein would also account for decreased levels of SP in adults.
So perhaps a more accurate conclusion to draw would be that increases in early postnatal
inflammatory mediators in the airways could result in altered SP protein synthesis, whether the
difference lies at the level of transcription or translation or both needs to be elucidated.
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6.3 Conclusions and Implications
Overall the studies conducted as part of this dissertation reveal that early postnatal life
between birth and PD10 is a period of rapid growth and development in the airway. The airway
specific parameters (epithelium NFD, NGF in BALF, and airway neuron numbers) measured
during normal postnatal development changed in an age-related manner, and fluctuated in the
same direction and on the same postnatal days. Based on data presented in Chapter 5 it can
also be concluded that the postnatal development of sensory neurons in the nodose and jugular
ganglia can be disrupted by a single early life O 3 exposure.
The large deficit in total neuron number following O3 exposure may represent
suppressed neuronal development rather than O3-induced cell death. Ganglia removed from
PD21 rats weighed markedly less in the O3-exposed groups compared with FA-exposed rat
pups, which might also indicate developmental deficiencies. Despite the large differences in
total neuron numbers between O3-exposed and FA-exposed animals no differences were noted
in the numbers of airway neurons. This result might signify a protective effect of O3 exposure on
airway neurons, a mechanism that may be mediated through the release of neurotrophins in the
airways. Early postnatal O3 exposure increases NGF protein and mRNA in the airways 24 hrs
after exposure (8) and populations of neurons in both vagal ganglia are reliant on NGF for
trophic support during development (5, 20); indicating that increased availability of trophic
factors in the airways might allow airway neurons to overcome the developmental deficiencies
that affected non-airway neurons. When also taking into account the increases in the numbers
SP positive airway neurons, the results of these studies may provide insight for how early life O 3
exposure results in enhanced airway sensitivity to secondary exposures in later life.
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Puce A, McNeely M, Carrick O, Berrebi M, Epling J, Thompson JC, Hardee JE, Zellner L,
Brefczynski-Lewis J. N170 amplitude reflects the seen number of faces irrespective of low-level
stimulus variables. OHBM Annual Scientific Meeting. #714
Zellner L, Batchelor T, Hunter D, Dey R. Sensory innervation of the tracheal epithelium: a role for
st
NGF”. 1 place poster competition Van Liere Research Convocation: Morgantown, WV.

2007

Zellner L, Hunter D, Batchelor T, Dey R. Postnatal development of airway sensory neurons.
American Thoracic Society International Meeting: San Francisco, CA.
Zellner L, Hunter D, Batchelor T, Dey R. Airway sensory neuron development in postnatal fisher
344 rats. Platform presentation and poster Minority Trainee Research Forum: Miami, FL.
Zellner L, Batchelor T, Dey R. Postnatal development of airway sensory neurons. Van Liere
Research Convocation: Morgantown, WV.
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Honors and Awards:
2007- 2010
Fellow; F31 Predoctoral Ruth L Kirschstein National Research Service Award
st

2008

1 Place Poster Competition: WVU Van Liere Research Convocation

2007

Travel Award; American Thoracic Society International Annual Scientific Meeting
Abstract Award: Minority Trainee Research Forum

Teaching:
2009 Coursework: Teaching practicum (PSIO 790), Dr. Mark Paternostro, West Virginia University
2008

Tutor; Elementary physiology (PSIO 241), coordinator Dr. Stan Yokota, West Virginia University

2007

Lecturer; Mechanisms of Body Function (PSIO 441), coordinator Dr. Laurie Sherwood West
Virginia University

2006

Lecturer; Mechanisms of Body Function (PSIO 441), coordinator Dr. Laurie Sherwood West
Virginia University

2005

Moderator; Physiology Small Group in Human Function (CCMD 730), coordinator Dr. Robert
Goodman West Virginia University

2004

Moderator; Physiology Small Group in Human Function (CCMD 730), coordinator Dr. Robert
Goodman West Virginia University
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